{"rsnumber": "rs5745687", "core_attributes": {"allele_string": "C/T", "position": "81729735", "synonyms": ["rs60736184", "RCV000036555", "rs386599734", "VAR_019199"], "chromosome": "7"}, "genename": "HGF", "genotype_frequency": "[{\"CSHL-HAPMAP:HapMap-JPT\": {\"C/C\": {\"count\": \"45\", \"frequency\": \"1\"}}}, {\"SNP500CANCER:AFR1\": {\"C/C\": {\"count\": \"24\", \"frequency\": \"1\"}}}, {\"SNP500CANCER:PAC1\": {\"C/C\": {\"count\": \"23\", \"frequency\": \"1\"}}}, {\"CSHL-HAPMAP:HapMap-JPT\": {\"C/C\": {\"count\": \"43\", \"frequency\": \"1\"}}}, {\"CSHL-HAPMAP:HapMap-YRI\": {\"C/C\": {\"count\": \"60\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_Watson\": {\"C/C\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_Venter\": {\"C/C\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"BUSHMAN:BUSHMAN_POP2\": {\"T/C\": {\"count\": \"1\", \"frequency\": \"1\"}}}]", "1000-genomes": {"GWD": {"11": 0, "0": 226, "00": 113, "01": 0, "1": 0}, "ACB": {"11": 0, "0": 191, "00": 95, "01": 1, "1": 1}, "BEB": {"11": 0, "0": 172, "00": 86, "01": 0, "1": 0}, "PEL": {"11": 0, "0": 167, "00": 82, "01": 3, "1": 3}, "LWK": {"11": 0, "0": 198, "00": 99, "01": 0, "1": 0}, "MSL": {"11": 0, "0": 170, "00": 85, "01": 0, "1": 0}, "GBR": {"11": 1, "0": 167, "00": 78, "01": 11, "1": 13}, "IBS": {"11": 0, "0": 205, "00": 98, "01": 9, "1": 9}, "ASW": {"11": 0, "0": 122, "00": 61, "01": 0, "1": 0}, "TSI": {"11": 1, "0": 197, "00": 91, "01": 15, "1": 17}, "KHV": {"11": 0, "0": 198, "00": 99, "01": 0, "1": 0}, "CEU": {"11": 0, "0": 186, "00": 87, "01": 12, "1": 12}, "SAS": {"11": 0, "0": 971, "00": 482, "01": 7, "1": 7}, "EAS": {"11": 0, "0": 1005, "00": 501, "01": 3, "1": 3}, "AMR": {"11": 0, "0": 664, "00": 317, "01": 30, "1": 30}, "YRI": {"11": 0, "0": 216, "00": 108, "01": 0, "1": 0}, "CHB": {"11": 0, "0": 205, "00": 102, "01": 1, "1": 1}, "STU": {"11": 0, "0": 203, "00": 101, "01": 1, "1": 1}, "CHS": {"11": 0, "0": 209, "00": 104, "01": 1, "1": 1}, "ESN": {"11": 0, "0": 198, "00": 99, "01": 0, "1": 0}, "FIN": {"11": 0, "0": 191, "00": 92, "01": 7, "1": 7}, "AFR": {"11": 0, "0": 1321, "00": 660, "01": 1, "1": 1}, "GIH": {"11": 0, "0": 203, "00": 100, "01": 3, "1": 3}, "PJL": {"11": 0, "0": 189, "00": 93, "01": 3, "1": 3}, "EUR": {"11": 2, "0": 946, "00": 446, "01": 54, "1": 58}, "MXL": {"11": 0, "0": 123, "00": 59, "01": 5, "1": 5}, "PUR": {"11": 0, "0": 198, "00": 94, "01": 10, "1": 10}, "ITU": {"11": 0, "0": 204, "00": 102, "01": 0, "1": 0}, "CDX": {"11": 0, "0": 185, "00": 92, "01": 1, "1": 1}, "JPT": {"11": 0, "0": 208, "00": 104, "01": 0, "1": 0}, "CLM": {"11": 0, "0": 176, "00": 82, "01": 12, "1": 12}}, "version": "0.1", "effects": [{"genotype": "A/T", "odd_ratio": "", "title": "Genome-Wide Association Study for Endothelial Growth Factors.", "risk_allele": "T", "journal": "Circ Cardiovasc Genet", "initial": "up to 3,574 European ancestry individuals", "mapped_trait": "endothelial growth factor measurement, hepatocyte growth factor measurement", "effect": "Endothelial growth factor levels", "evidences": "Initial: up to 3,574 European ancestry individuals, replication: up to 3,184 European ancestry individuals", "replication": "up to 3,184 European ancestry individuals", "author": "Lieb W", "date": "2014-12-31", "risk_allele_frequency": "", "pmid": "25552591", "risk": "Increased risk of Endothelial growth factor levels", "population": ["Global"]}]}
{"rsnumber": "rs1805126", "disgenet-diseases": [{"disease": "Electrocardiographic conduction measures", "pubmedid": "23463857", "sentence": ""}], "core_attributes": {"allele_string": "A/G", "position": "38550915", "synonyms": ["rs59992694", "rs2228994", "rs117610235", "rs17215486", "RCV000041627"], "chromosome": "3"}, "genename": "SCN5A", "genotype_frequency": "[{\"ENSEMBL:ENSEMBL_Venter\": {\"A/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ILLUMINA-UK:YRI\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_Watson\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:CEU\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:YRI\": {\"G/G\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"BUSHMAN:BUSHMAN_POP\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"BUSHMAN:BUSHMAN_POP2\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}]", "1000-genomes": {"GWD": {"11": 61, "0": 58, "00": 6, "01": 46, "1": 168}, "ACB": {"11": 40, "0": 67, "00": 11, "01": 45, "1": 125}, "BEB": {"11": 11, "0": 125, "00": 50, "01": 25, "1": 47}, "PEL": {"11": 27, "0": 75, "00": 17, "01": 41, "1": 95}, "LWK": {"11": 56, "0": 46, "00": 3, "01": 40, "1": 152}, "MSL": {"11": 37, "0": 55, "00": 7, "01": 41, "1": 115}, "GBR": {"11": 8, "0": 119, "00": 37, "01": 45, "1": 61}, "IBS": {"11": 10, "0": 150, "00": 53, "01": 44, "1": 64}, "ASW": {"11": 19, "0": 46, "00": 4, "01": 38, "1": 76}, "TSI": {"11": 14, "0": 136, "00": 43, "01": 50, "1": 78}, "KHV": {"11": 35, "0": 77, "00": 13, "01": 51, "1": 121}, "CEU": {"11": 11, "0": 133, "00": 45, "01": 43, "1": 65}, "SAS": {"11": 55, "0": 683, "00": 249, "01": 185, "1": 295}, "EAS": {"11": 158, "0": 428, "00": 82, "01": 264, "1": 580}, "AMR": {"11": 63, "0": 394, "00": 110, "01": 174, "1": 300}, "YRI": {"11": 58, "0": 60, "00": 10, "01": 40, "1": 156}, "CHB": {"11": 33, "0": 90, "00": 20, "01": 50, "1": 116}, "STU": {"11": 9, "0": 138, "00": 45, "01": 48, "1": 66}, "CHS": {"11": 35, "0": 88, "00": 18, "01": 52, "1": 122}, "ESN": {"11": 42, "0": 66, "00": 9, "01": 48, "1": 132}, "FIN": {"11": 28, "0": 99, "00": 28, "01": 43, "1": 99}, "AFR": {"11": 313, "0": 398, "00": 50, "01": 298, "1": 924}, "GIH": {"11": 12, "0": 145, "00": 54, "01": 37, "1": 61}, "PJL": {"11": 16, "0": 123, "00": 43, "01": 37, "1": 69}, "EUR": {"11": 71, "0": 637, "00": 206, "01": 225, "1": 367}, "MXL": {"11": 8, "0": 76, "00": 20, "01": 36, "1": 52}, "PUR": {"11": 15, "0": 122, "00": 33, "01": 56, "1": 86}, "ITU": {"11": 7, "0": 152, "00": 57, "01": 38, "1": 52}, "CDX": {"11": 32, "0": 71, "00": 10, "01": 51, "1": 115}, "JPT": {"11": 23, "0": 102, "00": 21, "01": 60, "1": 106}, "CLM": {"11": 13, "0": 121, "00": 40, "01": 41, "1": 67}}, "version": "0.1", "effects": [{"genotype": "T/A", "odd_ratio": "", "title": "Genome- and phenome-wide analyses of cardiac conduction identifies markers of arrhythmia risk.", "risk_allele": "A", "journal": "Circulation", "initial": "5,272 European ancestry indiviudals", "mapped_trait": "QRS duration", "effect": "Electrocardiographic conduction measures", "evidences": "Initial: 5,272 European ancestry indiviudals, replication: 40,407 European ancestry individuals", "replication": "40,407 European ancestry individuals", "author": "Ritchie MD", "date": "2013-03-05", "risk_allele_frequency": "", "pmid": "23463857", "risk": "Increased risk of Electrocardiographic conduction measures", "population": ["Global"]}], "associated_diseases": ["Electrocardiographic conduction measures"]}
{"rsnumber": "rs3733402", "disgenet-diseases": [{"disease": "B-type natriuretic peptide", "pubmedid": "25561047", "sentence": ""}, {"disease": "Serum metabolite levels", "pubmedid": "24625756", "sentence": ""}, {"disease": "Serum metabolite levels", "pubmedid": "24625756", "sentence": ""}, {"disease": "Obesity-related traits", "pubmedid": "23251661", "sentence": ""}, {"disease": "Metabolite levels (small molecules and protein measures)", "pubmedid": "27005778", "sentence": ""}], "core_attributes": {"allele_string": "G/A/C", "position": "186236880", "synonyms": ["rs28397785", "rs117872102", "RCV000012817", "6291", "rs52802208", "VAR_013598"], "chromosome": "4"}, "genename": "KLKB1", "genotype_frequency": "[{\"ENSEMBL:ENSEMBL_Watson\": {\"G/G\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ILLUMINA-UK:YRI\": {\"A/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_Venter\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:CEU\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:YRI\": {\"A/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:PGP\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"BUSHMAN:BUSHMAN_POP\": {\"G/A\": {\"count\": \"2\", \"frequency\": \"1\"}}}]", "1000-genomes": {"GWD": {"11": 69, "0": 49, "00": 5, "01": 39, "1": 177}, "ACB": {"11": 48, "0": 52, "00": 4, "01": 44, "1": 140}, "BEB": {"11": 12, "0": 102, "00": 28, "01": 46, "1": 70}, "PEL": {"11": 35, "0": 64, "00": 14, "01": 36, "1": 106}, "LWK": {"11": 66, "0": 36, "00": 3, "01": 30, "1": 162}, "MSL": {"11": 43, "0": 50, "00": 8, "01": 34, "1": 120}, "GBR": {"11": 24, "0": 88, "00": 22, "01": 44, "1": 92}, "IBS": {"11": 28, "0": 100, "00": 21, "01": 58, "1": 114}, "ASW": {"11": 33, "0": 31, "00": 3, "01": 25, "1": 91}, "TSI": {"11": 26, "0": 106, "00": 25, "01": 56, "1": 108}, "KHV": {"11": 47, "0": 64, "00": 12, "01": 40, "1": 134}, "CEU": {"11": 27, "0": 101, "00": 29, "01": 43, "1": 97}, "SAS": {"11": 76, "0": 594, "00": 181, "01": 232, "1": 384}, "EAS": {"11": 233, "0": 321, "00": 50, "01": 221, "1": 687}, "AMR": {"11": 131, "0": 278, "00": 62, "01": 154, "1": 416}, "YRI": {"11": 67, "0": 46, "00": 5, "01": 36, "1": 170}, "CHB": {"11": 38, "0": 70, "00": 5, "01": 60, "1": 136}, "STU": {"11": 11, "0": 138, "00": 47, "01": 44, "1": 66}, "CHS": {"11": 51, "0": 66, "00": 12, "01": 42, "1": 144}, "ESN": {"11": 64, "0": 40, "00": 5, "01": 30, "1": 158}, "FIN": {"11": 34, "0": 87, "00": 22, "01": 43, "1": 111}, "AFR": {"11": 390, "0": 304, "00": 33, "01": 238, "1": 1018}, "GIH": {"11": 16, "0": 126, "00": 39, "01": 48, "1": 80}, "PJL": {"11": 24, "0": 96, "00": 24, "01": 48, "1": 96}, "EUR": {"11": 139, "0": 482, "00": 119, "01": 244, "1": 522}, "MXL": {"11": 23, "0": 54, "00": 13, "01": 28, "1": 74}, "PUR": {"11": 31, "0": 92, "00": 19, "01": 54, "1": 116}, "ITU": {"11": 13, "0": 132, "00": 43, "01": 46, "1": 72}, "CDX": {"11": 54, "0": 44, "00": 5, "01": 34, "1": 142}, "JPT": {"11": 43, "0": 77, "00": 16, "01": 45, "1": 131}, "CLM": {"11": 42, "0": 68, "00": 16, "01": 36, "1": 120}}, "version": "0.1", "effects": [{"genotype": "C/G", "odd_ratio": "", "title": "Genome-Wide Association Analysis of Plasma B-Type Natriuretic Peptide in African Americans: The Jackson Heart Study.", "risk_allele": "G", "journal": "Circ Cardiovasc Genet", "initial": "2,790 Black individuals", "mapped_trait": "BNP measurement", "effect": "B-type natriuretic peptide", "evidences": "Initial: 2,790 Black individuals, replication: NA", "replication": "NA", "author": "Musani SK", "date": "2015-01-05", "risk_allele_frequency": "", "pmid": "25561047", "risk": "Increased risk of B-type natriuretic peptide", "population": ["Global"]}, {"genotype": "T/A", "odd_ratio": "", "title": "Genetic determinants influencing human serum metabolome among African Americans.", "risk_allele": "A", "journal": "PLoS Genet", "initial": "1,260 African American individuals", "mapped_trait": "serum metabolite measurement", "effect": "Serum metabolite levels", "evidences": "Initial: 1,260 African American individuals, replication: NA", "replication": "NA", "author": "Yu B", "date": "2014-03-13", "risk_allele_frequency": "", "pmid": "24625756", "risk": "Increased risk of Serum metabolite levels", "population": ["Global"]}, {"genotype": "T/A", "odd_ratio": "", "title": "Genetic determinants influencing human serum metabolome among African Americans.", "risk_allele": "A", "journal": "PLoS Genet", "initial": "1,260 African American individuals", "mapped_trait": "serum metabolite measurement", "effect": "Serum metabolite levels", "evidences": "Initial: 1,260 African American individuals, replication: NA", "replication": "NA", "author": "Yu B", "date": "2014-03-13", "risk_allele_frequency": "", "pmid": "24625756", "risk": "Increased risk of Serum metabolite levels", "population": ["Global"]}, {"genotype": "C/G", "odd_ratio": "", "title": "Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.", "risk_allele": "G", "journal": "PLoS One", "initial": "815 Hispanic children from 263 families", "mapped_trait": "IGF-1 measurement", "effect": "Obesity-related traits", "evidences": "Initial: 815 Hispanic children from 263 families, replication: NA", "replication": "NA", "author": "Comuzzie AG", "date": "2012-12-04", "risk_allele_frequency": "", "pmid": "23251661", "risk": "Increased risk of Obesity-related traits", "population": ["Global"]}, {"genotype": "T/A", "odd_ratio": "", "title": "Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA.", "risk_allele": "A", "journal": "Nat Commun", "initial": "2,118 Erasmus Rucphen (founder/genetic isolate), 22,807 European ancestry individuals", "mapped_trait": "blood metabolite measurement, protein measurement, amino acid measurement", "effect": "Metabolite levels (small molecules and protein measures)", "evidences": "Initial: 2,118 Erasmus Rucphen (founder/genetic isolate), 22,807 European ancestry individuals, replication: NA", "replication": "NA", "author": "Kettunen J", "date": "2016-03-23", "risk_allele_frequency": "", "pmid": "27005778", "risk": "Increased risk of Metabolite levels (small molecules and protein measures)", "population": ["Global"]}], "associated_diseases": ["B-type natriuretic peptide", "Serum metabolite levels", "Serum metabolite levels", "Obesity-related traits", "Metabolite levels (small molecules and protein measures)"]}
{"rsnumber": "rs2403254", "core_attributes": {"allele_string": "C/T", "position": "18303599", "synonyms": ["rs74232540", "RCV000170568", "rs60431360"], "chromosome": "11"}, "genename": "HPS5", "genotype_frequency": "[{\"COMPLETE_GENOMICS:CEU\": {\"T/T\": {\"count\": \"1\", \"frequency\": \"1\"}}}]", "1000-genomes": {"GWD": {"11": 2, "0": 205, "00": 94, "01": 17, "1": 21}, "ACB": {"11": 6, "0": 158, "00": 68, "01": 22, "1": 34}, "BEB": {"11": 21, "0": 84, "00": 19, "01": 46, "1": 88}, "PEL": {"11": 24, "0": 87, "00": 26, "01": 35, "1": 83}, "LWK": {"11": 1, "0": 178, "00": 80, "01": 18, "1": 20}, "MSL": {"11": 1, "0": 157, "00": 73, "01": 11, "1": 13}, "GBR": {"11": 30, "0": 77, "00": 17, "01": 43, "1": 103}, "IBS": {"11": 28, "0": 101, "00": 22, "01": 57, "1": 113}, "ASW": {"11": 5, "0": 97, "00": 41, "01": 15, "1": 25}, "TSI": {"11": 30, "0": 96, "00": 19, "01": 58, "1": 118}, "KHV": {"11": 36, "0": 84, "00": 21, "01": 42, "1": 114}, "CEU": {"11": 31, "0": 88, "00": 20, "01": 48, "1": 110}, "SAS": {"11": 117, "0": 503, "00": 131, "01": 241, "1": 475}, "EAS": {"11": 179, "0": 419, "00": 94, "01": 231, "1": 589}, "AMR": {"11": 83, "0": 351, "00": 87, "01": 177, "1": 343}, "YRI": {"11": 1, "0": 197, "00": 90, "01": 17, "1": 19}, "CHB": {"11": 27, "0": 96, "00": 20, "01": 56, "1": 110}, "STU": {"11": 40, "0": 75, "00": 13, "01": 49, "1": 129}, "CHS": {"11": 38, "0": 81, "00": 14, "01": 53, "1": 129}, "ESN": {"11": 0, "0": 184, "00": 85, "01": 14, "1": 14}, "FIN": {"11": 24, "0": 100, "00": 25, "01": 50, "1": 98}, "AFR": {"11": 16, "0": 1176, "00": 531, "01": 114, "1": 146}, "GIH": {"11": 18, "0": 121, "00": 36, "01": 49, "1": 85}, "PJL": {"11": 17, "0": 115, "00": 36, "01": 43, "1": 77}, "EUR": {"11": 143, "0": 462, "00": 103, "01": 256, "1": 542}, "MXL": {"11": 14, "0": 63, "00": 13, "01": 37, "1": 65}, "PUR": {"11": 30, "0": 100, "00": 26, "01": 48, "1": 108}, "ITU": {"11": 21, "0": 108, "00": 27, "01": 54, "1": 96}, "CDX": {"11": 46, "0": 63, "00": 16, "01": 31, "1": 123}, "JPT": {"11": 32, "0": 95, "00": 23, "01": 49, "1": 113}, "CLM": {"11": 15, "0": 101, "00": 22, "01": 57, "1": 87}}, "version": "0.1", "effects": [{"genotype": "A/T", "odd_ratio": "", "title": "Human metabolic individuality in biomedical and pharmaceutical research.", "risk_allele": "T", "journal": "Nature", "initial": "2,820 European ancestry individuals", "mapped_trait": "metabolite measurement", "effect": "Metabolic traits", "evidences": "Initial: 2,820 European ancestry individuals, replication: NA", "replication": "NA", "author": "Suhre K", "date": "2011-08-31", "risk_allele_frequency": "", "pmid": "21886157", "risk": "Increased risk of Metabolic traits", "population": ["Global"]}, {"genotype": "A/T", "odd_ratio": "", "title": "An atlas of genetic influences on human blood metabolites.", "risk_allele": "T", "journal": "Nat Genet", "initial": "7,824 European ancestry individuals", "mapped_trait": "blood metabolite measurement", "effect": "Blood metabolite levels", "evidences": "Initial: 7,824 European ancestry individuals, replication: NA", "replication": "NA", "author": "Shin SY", "date": "2014-05-11", "risk_allele_frequency": "", "pmid": "24816252", "risk": "Increased risk of Blood metabolite levels", "population": ["Global"]}]}
{"rsnumber": "rs334", "disgenet-diseases": [{"disease": "Anemia", "pubmedid": "24312262", "sentence": "Furthermore, IL17RE rs708567 GA and hHbS rs334 AT individuals were associated with protection from uncomplicated malaria and anaemia respectively in this study."}, {"disease": "Malaria", "pubmedid": "24312262", "sentence": "Furthermore, IL17RE rs708567 GA and hHbS rs334 AT individuals were associated with protection from uncomplicated malaria and anaemia respectively in this study."}, {"disease": "Sickle Cell Trait", "pubmedid": "20552021", "sentence": "The objective was to investigate whether haptoglobin (Hp) haplotypes constructed from the functional polymorphism (Hp1/Hp2) plus the functional promoter SNPs -61A-C (rs5471) and -101C-G (rs5470), or sickle cell trait (HbAS, rs334) were associated with risk of active trachoma when stratified by age and sex, in rural Gambian children."}, {"disease": "Trachoma", "pubmedid": "20552021", "sentence": "The objective was to investigate whether haptoglobin (Hp) haplotypes constructed from the functional polymorphism (Hp1/Hp2) plus the functional promoter SNPs -61A-C (rs5471) and -101C-G (rs5470), or sickle cell trait (HbAS, rs334) were associated with risk of active trachoma when stratified by age and sex, in rural Gambian children."}, {"disease": "Anemia", "pubmedid": "22244832", "sentence": "Hb S-S\u00e3o Paulo (SP) [HBB:c.20A&gt;T p.Glu6Val; c.196A&gt;G p.Lys65Glu] is a new double-mutant hemoglobin that was found in heterozygosis in an 18-month-old Brazilian male with moderate anemia."}, {"disease": "Sickle Cell Trait", "pubmedid": "20552021", "sentence": "The objective was to investigate whether haptoglobin (Hp) haplotypes constructed from the functional polymorphism (Hp1/Hp2) plus the functional promoter SNPs -61A-C (rs5471) and -101C-G (rs5470), or sickle cell trait (HbAS, rs334) were associated with risk of active trachoma when stratified by age and sex, in rural Gambian children."}, {"disease": "Anemia", "pubmedid": "24312262", "sentence": "Meanwhile, individuals with the hHbS rs334 TT, IL10 rs3024500 AA, and IL17RD rs6780995 GA genotypes were more susceptible to severe malarial anaemia, cerebral malaria, and hyperpyrexia respectively."}], "core_attributes": {"allele_string": "T/A/C/G", "position": "5227002", "synonyms": ["2964", "VAR_002863", "rs77121243", "2580", "2806", "RCV000016877", "RCV000016575", "RCV000016574", "RCV000016352", "RCV000016579", "rs34315575", "228", "RCV000016286", "226", "VAR_002862", "RCV000016577", "rs3168321", "RCV000016573"], "chromosome": "11"}, "genename": "HBB", "genotype_frequency": "[{\"CSHL-HAPMAP:HapMap-CEU\": {\"T/T\": {\"count\": \"59\", \"frequency\": \"1\"}}}, {\"CSHL-HAPMAP:HapMap-HCB\": {\"T/T\": {\"count\": \"45\", \"frequency\": \"1\"}}}, {\"CSHL-HAPMAP:HapMap-JPT\": {\"T/T\": {\"count\": \"45\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_Watson\": {\"T/T\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"CSHL-HAPMAP:HapMap-CEU\": {\"T/T\": {\"count\": \"60\", \"frequency\": \"1\"}}}, {\"CSHL-HAPMAP:HapMap-HCB\": {\"T/T\": {\"count\": \"45\", \"frequency\": \"1\"}}}, {\"CSHL-HAPMAP:HapMap-JPT\": {\"T/T\": {\"count\": \"45\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:YRI\": {\"T/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}]", "1000-genomes": {"GWD": {"11": 0, "0": 204, "00": 91, "01": 22, "1": 22}, "ACB": {"11": 0, "0": 185, "00": 89, "01": 7, "1": 7}, "BEB": {"11": 0, "0": 171, "00": 85, "01": 1, "1": 1}, "PEL": {"11": 0, "0": 170, "00": 85, "01": 0, "1": 0}, "LWK": {"11": 0, "0": 178, "00": 79, "01": 20, "1": 20}, "MSL": {"11": 0, "0": 150, "00": 65, "01": 20, "1": 20}, "GBR": {"11": 0, "0": 180, "00": 90, "01": 0, "1": 0}, "IBS": {"11": 0, "0": 214, "00": 107, "01": 0, "1": 0}, "ASW": {"11": 0, "0": 120, "00": 59, "01": 2, "1": 2}, "TSI": {"11": 0, "0": 214, "00": 107, "01": 0, "1": 0}, "KHV": {"11": 0, "0": 196, "00": 97, "01": 2, "1": 2}, "CEU": {"11": 0, "0": 198, "00": 99, "01": 0, "1": 0}, "SAS": {"11": 0, "0": 975, "00": 486, "01": 3, "1": 3}, "EAS": {"11": 0, "0": 1006, "00": 502, "01": 2, "1": 2}, "AMR": {"11": 0, "0": 689, "00": 342, "01": 5, "1": 5}, "YRI": {"11": 0, "0": 186, "00": 78, "01": 30, "1": 30}, "CHB": {"11": 0, "0": 206, "00": 103, "01": 0, "1": 0}, "STU": {"11": 0, "0": 204, "00": 102, "01": 0, "1": 0}, "CHS": {"11": 0, "0": 210, "00": 105, "01": 0, "1": 0}, "ESN": {"11": 0, "0": 172, "00": 73, "01": 26, "1": 26}, "FIN": {"11": 0, "0": 198, "00": 99, "01": 0, "1": 0}, "AFR": {"11": 0, "0": 1195, "00": 534, "01": 127, "1": 127}, "GIH": {"11": 0, "0": 206, "00": 103, "01": 0, "1": 0}, "PJL": {"11": 0, "0": 190, "00": 94, "01": 2, "1": 2}, "EUR": {"11": 0, "0": 1004, "00": 502, "01": 0, "1": 0}, "MXL": {"11": 0, "0": 128, "00": 64, "01": 0, "1": 0}, "PUR": {"11": 0, "0": 205, "00": 101, "01": 3, "1": 3}, "ITU": {"11": 0, "0": 204, "00": 102, "01": 0, "1": 0}, "CDX": {"11": 0, "0": 186, "00": 93, "01": 0, "1": 0}, "JPT": {"11": 0, "0": 208, "00": 104, "01": 0, "1": 0}, "CLM": {"11": 0, "0": 186, "00": 92, "01": 2, "1": 2}}, "version": "0.1", "effects": [{"genotype": "A/T", "odd_ratio": "", "title": "African Ancestry-Specific Alleles and Kidney Disease Risk in Hispanics/Latinos.", "risk_allele": "T", "journal": "J Am Soc Nephrol", "initial": "5,458 Caribbean Hispanic/Latino individuals, 6,734 Mainland Hispanic/Latino individuals, 34 Hispanic/Latino individuals", "mapped_trait": "urinary albumin to creatinine ratio", "effect": "Urinary albumin-to-creatinine ratio", "evidences": "Initial: 5,458 Caribbean Hispanic/Latino individuals, 6,734 Mainland Hispanic/Latino individuals, 34 Hispanic/Latino individuals, replication: NA", "replication": "NA", "author": "Kramer HJ", "date": "2016-09-20", "risk_allele_frequency": "", "pmid": "27650483", "risk": "Increased risk of Urinary albumin-to-creatinine ratio", "population": ["Global"]}, {"genotype": "A/T", "odd_ratio": "", "title": "African Ancestry-Specific Alleles and Kidney Disease Risk in Hispanics/Latinos.", "risk_allele": "T", "journal": "J Am Soc Nephrol", "initial": "5,458 Caribbean Hispanic/Latino individuals, 6,734 Mainland Hispanic/Latino individuals, 34 Hispanic/Latino individuals", "mapped_trait": "urinary albumin to creatinine ratio", "effect": "Urinary albumin-to-creatinine ratio", "evidences": "Initial: 5,458 Caribbean Hispanic/Latino individuals, 6,734 Mainland Hispanic/Latino individuals, 34 Hispanic/Latino individuals, replication: NA", "replication": "NA", "author": "Kramer HJ", "date": "2016-09-20", "risk_allele_frequency": "", "pmid": "27650483", "risk": "Increased risk of Urinary albumin-to-creatinine ratio", "population": ["Global"]}], "associated_diseases": ["Anemia", "Malaria", "Sickle Cell Trait", "Trachoma", "Anemia", "Sickle Cell Trait", "Anemia"]}
{"rsnumber": "rs2230926", "disgenet-diseases": [{"disease": "Rheumatoid Arthritis", "pubmedid": "23577190", "sentence": "Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2)."}, {"disease": "Rheumatoid Arthritis", "pubmedid": "23577190", "sentence": "Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2)."}, {"disease": "Rheumatoid Arthritis", "pubmedid": "23577190", "sentence": "Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2)."}, {"disease": "Rheumatoid Arthritis", "pubmedid": "23577190", "sentence": "Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2)."}, {"disease": "Rheumatoid Arthritis", "pubmedid": "23577190", "sentence": "Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2)."}, {"disease": "Lupus Erythematosus, Systemic", "pubmedid": "20617138", "sentence": "Association of rs2230926 G allele with SLE was replicated in Japanese (allelic association P = .033, odds ratio [OR] 1.47, recessive model P = .023, OR 8.52)."}, {"disease": "Rheumatoid Arthritis", "pubmedid": "23577190", "sentence": "Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2)."}, {"disease": "Arthritis", "pubmedid": "19774492", "sentence": "Interestingly, rs2230926 of TNFAIP3 was also associated with arthritis, ANA and some other subphenotypes of the disease."}, {"disease": "Rheumatoid Arthritis", "pubmedid": "23577190", "sentence": "Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2)."}, {"disease": "Rheumatoid Arthritis", "pubmedid": "25674272", "sentence": "TNFAIP3 rs2230926 polymorphisms in rheumatoid arthritis of southern Chinese Han population: a case-control study."}, {"disease": "Lupus Erythematosus, Systemic", "pubmedid": "20483768", "sentence": "There are two nonsynonymous coding polymorphisms in the deubiquitinating (DUB) domain of TNFAIP3: F127C, which is in high-linkage disequilibrium with reported SLE-risk variants, and A125V, which has not been previously studied."}, {"disease": "Lupus Erythematosus, Systemic", "pubmedid": "23911423", "sentence": "Associations of TNFAIP3 rs2230926 (p=1.43 \u00d7 10(-3)) and TNIP1 rs10036748 (p=4.33 \u00d7 10(-3)) with SLE were replicated in our study."}, {"disease": "Rheumatoid Arthritis", "pubmedid": "23577190", "sentence": "Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2)."}, {"disease": "Rheumatoid Arthritis", "pubmedid": "23577190", "sentence": "Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2)."}, {"disease": "Rheumatoid Arthritis", "pubmedid": "23577190", "sentence": "Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2)."}], "core_attributes": {"allele_string": "T/C/G", "position": "137874929", "synonyms": ["rs61407535", "RCV000122149", "rs5029942", "rs52802446", "VAR_022143"], "chromosome": "6"}, "genename": "TNFAIP3", "genotype_frequency": "[{\"ENSEMBL:ENSEMBL_Watson\": {\"T/T\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ILLUMINA-UK:YRI\": {\"T/G\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"BUSHMAN:BUSHMAN_POP\": {\"T/G\": {\"count\": \"2\", \"frequency\": \"1\"}}}, {\"BUSHMAN:BANTU\": {\"T/G\": {\"count\": \"1\", \"frequency\": \"1\"}}}]", "1000-genomes": {"GWD": {"11": 27, "0": 118, "00": 32, "01": 54, "1": 108}, "ACB": {"11": 6, "0": 144, "00": 54, "01": 36, "1": 48}, "BEB": {"11": 0, "0": 168, "00": 82, "01": 4, "1": 4}, "PEL": {"11": 1, "0": 157, "00": 73, "01": 11, "1": 13}, "LWK": {"11": 5, "0": 130, "00": 36, "01": 58, "1": 68}, "MSL": {"11": 17, "0": 91, "00": 23, "01": 45, "1": 79}, "GBR": {"11": 0, "0": 175, "00": 85, "01": 5, "1": 5}, "IBS": {"11": 0, "0": 209, "00": 102, "01": 5, "1": 5}, "ASW": {"11": 9, "0": 84, "00": 32, "01": 20, "1": 38}, "TSI": {"11": 0, "0": 207, "00": 100, "01": 7, "1": 7}, "KHV": {"11": 0, "0": 191, "00": 92, "01": 7, "1": 7}, "CEU": {"11": 0, "0": 194, "00": 95, "01": 4, "1": 4}, "SAS": {"11": 1, "0": 941, "00": 453, "01": 35, "1": 37}, "EAS": {"11": 4, "0": 950, "00": 450, "01": 50, "1": 58}, "AMR": {"11": 3, "0": 635, "00": 291, "01": 53, "1": 59}, "YRI": {"11": 24, "0": 115, "00": 31, "01": 53, "1": 101}, "CHB": {"11": 1, "0": 192, "00": 90, "01": 12, "1": 14}, "STU": {"11": 0, "0": 196, "00": 94, "01": 8, "1": 8}, "CHS": {"11": 0, "0": 203, "00": 98, "01": 7, "1": 7}, "ESN": {"11": 17, "0": 118, "00": 36, "01": 46, "1": 80}, "FIN": {"11": 0, "0": 196, "00": 97, "01": 2, "1": 2}, "AFR": {"11": 105, "0": 800, "00": 244, "01": 312, "1": 522}, "GIH": {"11": 0, "0": 196, "00": 93, "01": 10, "1": 10}, "PJL": {"11": 1, "0": 178, "00": 83, "01": 12, "1": 14}, "EUR": {"11": 0, "0": 981, "00": 479, "01": 23, "1": 23}, "MXL": {"11": 0, "0": 125, "00": 61, "01": 3, "1": 3}, "PUR": {"11": 2, "0": 181, "00": 79, "01": 23, "1": 27}, "ITU": {"11": 0, "0": 203, "00": 101, "01": 1, "1": 1}, "CDX": {"11": 0, "0": 183, "00": 90, "01": 3, "1": 3}, "JPT": {"11": 3, "0": 181, "00": 80, "01": 21, "1": 27}, "CLM": {"11": 0, "0": 172, "00": 78, "01": 16, "1": 16}}, "version": "0.1", "effects": [{"genotype": "C/G", "odd_ratio": "", "title": "Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians.", "risk_allele": "G", "journal": "Am J Hum Genet", "initial": "1,656 Han Chinese ancestry cases, 3,394 Han Chinese ancestry controls", "mapped_trait": "systemic lupus erythematosus", "effect": "Systemic lupus erythematosus", "evidences": "Initial: 1,656 Han Chinese ancestry cases, 3,394 Han Chinese ancestry controls, replication: 3,256 Han Chinese ancestry cases, 5,667 Han Chinese ancestry controls, 453 Thai ancestry cases, 963 Thai ancestry controls", "replication": "3,256 Han Chinese ancestry cases, 5,667 Han Chinese ancestry controls, 453 Thai ancestry cases, 963 Thai ancestry controls", "author": "Yang W", "date": "2012-12-27", "risk_allele_frequency": "", "pmid": "23273568", "risk": "Increased risk of Systemic lupus erythematosus", "population": ["Global"]}, {"genotype": "G/C", "odd_ratio": "", "title": "Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus.", "risk_allele": "C", "journal": "Nat Genet", "initial": "1,047 Han Chinese ancestry cases, 1,205 Han Chinese ancestry controls", "mapped_trait": "systemic lupus erythematosus", "effect": "Systemic lupus erythematosus", "evidences": "Initial: 1,047 Han Chinese ancestry cases, 1,205 Han Chinese ancestry controls, replication: 3,152 Han Chinese ancestry cases, 7,050 Han Chinese ancestry controls", "replication": "3,152 Han Chinese ancestry cases, 7,050 Han Chinese ancestry controls", "author": "Han JW", "date": "2009-10-18", "risk_allele_frequency": "", "pmid": "19838193", "risk": "Increased risk of Systemic lupus erythematosus", "population": ["Global"]}, {"genotype": "G/C", "odd_ratio": "", "title": "A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility.", "risk_allele": "C", "journal": "Nat Genet", "initial": "2,303 Japanese ancestry cases, 3,380 Japanese ancestry controls", "mapped_trait": "rheumatoid arthritis", "effect": "Rheumatoid arthritis", "evidences": "Initial: 2,303 Japanese ancestry cases, 3,380 Japanese ancestry controls, replication: 4,768 Japanese ancestry cases, 17,359 Japanese ancestry controls", "replication": "4,768 Japanese ancestry cases, 17,359 Japanese ancestry controls", "author": "Kochi Y", "date": "2010-05-09", "risk_allele_frequency": "", "pmid": "20453841", "risk": "Increased risk of Rheumatoid arthritis", "population": ["Global"]}], "associated_diseases": ["Rheumatoid Arthritis", "Rheumatoid Arthritis", "Rheumatoid Arthritis", "Rheumatoid Arthritis", "Rheumatoid Arthritis", "Lupus Erythematosus, Systemic", "Rheumatoid Arthritis", "Arthritis", "Rheumatoid Arthritis", "Rheumatoid Arthritis", "Lupus Erythematosus, Systemic", "Lupus Erythematosus, Systemic", "Rheumatoid Arthritis", "Rheumatoid Arthritis", "Rheumatoid Arthritis"]}
{"rsnumber": "rs2942", "core_attributes": {"allele_string": "G/A", "position": "146434004", "synonyms": ["rs59678279", "RCV000117204", "rs362825"], "chromosome": "6"}, "genename": "GRM1", "genotype_frequency": "[{\"HUMANGENOME_JCVI:J. Craig Venter\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ILLUMINA-UK:YRI\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_Venter\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_Watson\": {\"A/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:CEU\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:PGP\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"BUSHMAN:BUSHMAN_POP\": {\"G/A\": {\"count\": \"2\", \"frequency\": \"1\"}}}]", "1000-genomes": {"GWD": {"11": 38, "0": 103, "00": 28, "01": 47, "1": 123}, "ACB": {"11": 27, "0": 94, "00": 25, "01": 44, "1": 98}, "BEB": {"11": 33, "0": 64, "00": 11, "01": 42, "1": 108}, "PEL": {"11": 14, "0": 113, "00": 42, "01": 29, "1": 57}, "LWK": {"11": 35, "0": 87, "00": 23, "01": 41, "1": 111}, "MSL": {"11": 18, "0": 96, "00": 29, "01": 38, "1": 74}, "GBR": {"11": 24, "0": 90, "00": 24, "01": 42, "1": 90}, "IBS": {"11": 40, "0": 89, "00": 22, "01": 45, "1": 125}, "ASW": {"11": 17, "0": 63, "00": 19, "01": 25, "1": 59}, "TSI": {"11": 36, "0": 88, "00": 17, "01": 54, "1": 126}, "KHV": {"11": 38, "0": 84, "00": 23, "01": 38, "1": 114}, "CEU": {"11": 28, "0": 89, "00": 18, "01": 53, "1": 109}, "SAS": {"11": 193, "0": 371, "00": 75, "01": 221, "1": 607}, "EAS": {"11": 159, "0": 460, "00": 115, "01": 230, "1": 548}, "AMR": {"11": 82, "0": 376, "00": 111, "01": 154, "1": 318}, "YRI": {"11": 23, "0": 118, "00": 33, "01": 52, "1": 98}, "CHB": {"11": 27, "0": 100, "00": 24, "01": 52, "1": 106}, "STU": {"11": 37, "0": 80, "00": 15, "01": 50, "1": 124}, "CHS": {"11": 29, "0": 98, "00": 22, "01": 54, "1": 112}, "ESN": {"11": 20, "0": 107, "00": 28, "01": 51, "1": 91}, "FIN": {"11": 28, "0": 98, "00": 27, "01": 44, "1": 100}, "AFR": {"11": 178, "0": 668, "00": 185, "01": 298, "1": 654}, "GIH": {"11": 38, "0": 84, "00": 19, "01": 46, "1": 122}, "PJL": {"11": 44, "0": 65, "00": 13, "01": 39, "1": 127}, "EUR": {"11": 156, "0": 454, "00": 108, "01": 238, "1": 550}, "MXL": {"11": 10, "0": 77, "00": 23, "01": 31, "1": 51}, "PUR": {"11": 33, "0": 92, "00": 21, "01": 50, "1": 116}, "ITU": {"11": 41, "0": 78, "00": 17, "01": 44, "1": 126}, "CDX": {"11": 30, "0": 85, "00": 22, "01": 41, "1": 101}, "JPT": {"11": 35, "0": 93, "00": 24, "01": 45, "1": 115}, "CLM": {"11": 25, "0": 94, "00": 25, "01": 44, "1": 94}}, "version": "0.1"}
{"rsnumber": "rs35152987", "core_attributes": {"allele_string": "C/A", "position": "5234352", "synonyms": ["rs386583305", "rs111692542", "RCV000016222", "660", "VAR_003105", "RCV000016221", "3285", "2010_April_001_162_HBD_142000_0028"], "chromosome": "11"}, "genename": "HBD", "genotype_frequency": "[{\"ENSEMBL:ENSEMBL_Watson\": {\"C/C\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_Venter\": {\"C/C\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"NHLBI-ESP:ESP_Cohort_Populations\": {\"A/A\": {\"count\": \"0\", \"frequency\": \"0\"}}}]", "1000-genomes": {"GWD": {"11": 0, "0": 226, "00": 113, "01": 0, "1": 0}, "ACB": {"11": 0, "0": 192, "00": 96, "01": 0, "1": 0}, "BEB": {"11": 0, "0": 172, "00": 86, "01": 0, "1": 0}, "PEL": {"11": 0, "0": 170, "00": 85, "01": 0, "1": 0}, "LWK": {"11": 0, "0": 198, "00": 99, "01": 0, "1": 0}, "MSL": {"11": 0, "0": 170, "00": 85, "01": 0, "1": 0}, "GBR": {"11": 0, "0": 179, "00": 89, "01": 1, "1": 1}, "IBS": {"11": 0, "0": 212, "00": 105, "01": 2, "1": 2}, "ASW": {"11": 0, "0": 122, "00": 61, "01": 0, "1": 0}, "TSI": {"11": 0, "0": 214, "00": 107, "01": 0, "1": 0}, "KHV": {"11": 0, "0": 198, "00": 99, "01": 0, "1": 0}, "CEU": {"11": 0, "0": 197, "00": 98, "01": 1, "1": 1}, "SAS": {"11": 0, "0": 977, "00": 488, "01": 1, "1": 1}, "EAS": {"11": 0, "0": 1008, "00": 504, "01": 0, "1": 0}, "AMR": {"11": 0, "0": 694, "00": 347, "01": 0, "1": 0}, "YRI": {"11": 0, "0": 216, "00": 108, "01": 0, "1": 0}, "CHB": {"11": 0, "0": 206, "00": 103, "01": 0, "1": 0}, "STU": {"11": 0, "0": 204, "00": 102, "01": 0, "1": 0}, "CHS": {"11": 0, "0": 210, "00": 105, "01": 0, "1": 0}, "ESN": {"11": 0, "0": 198, "00": 99, "01": 0, "1": 0}, "FIN": {"11": 0, "0": 198, "00": 99, "01": 0, "1": 0}, "AFR": {"11": 0, "0": 1322, "00": 661, "01": 0, "1": 0}, "GIH": {"11": 0, "0": 206, "00": 103, "01": 0, "1": 0}, "PJL": {"11": 0, "0": 192, "00": 96, "01": 0, "1": 0}, "EUR": {"11": 0, "0": 1000, "00": 498, "01": 4, "1": 4}, "MXL": {"11": 0, "0": 128, "00": 64, "01": 0, "1": 0}, "PUR": {"11": 0, "0": 208, "00": 104, "01": 0, "1": 0}, "ITU": {"11": 0, "0": 203, "00": 101, "01": 1, "1": 1}, "CDX": {"11": 0, "0": 186, "00": 93, "01": 0, "1": 0}, "JPT": {"11": 0, "0": 208, "00": 104, "01": 0, "1": 0}, "CLM": {"11": 0, "0": 188, "00": 94, "01": 0, "1": 0}}, "version": "0.1", "effects": [{"genotype": "T/A", "odd_ratio": "", "title": "Genome-wide association analyses based on whole-genome sequencing in Sardinia provide insights into regulation of hemoglobin levels.", "risk_allele": "A", "journal": "Nat Genet", "initial": "6,602 Sardinian founder individuals", "mapped_trait": "hemoglobin measurement, hemoglobin A2 measurement", "effect": "Hemoglobin levels", "evidences": "Initial: 6,602 Sardinian founder individuals, replication: 4,131 European ancestry individuals", "replication": "4,131 European ancestry individuals", "author": "Danjou F", "date": "2015-09-14", "risk_allele_frequency": "", "pmid": "26366553", "risk": "Increased risk of Hemoglobin levels", "population": ["Global"]}]}
{"rsnumber": "rs1801133", "disgenet-diseases": [{"disease": "Spina Bifida", "pubmedid": "19493349", "sentence": "With respect to spina bifida, we observed ORs with 95% confidence intervals that did not include 1.0 for the following SNPs (heterozygous or homozygous) relative to the reference genotype: BHMT (rs3733890) OR = 1.8 (1.1-3.1), CBS (rs2851391) OR = 2.0 (1.2-3.1); CBS (rs234713) OR = 2.9 (1.3-6.7); MTHFD1 (rs2236224) OR = 1.7 (1.1-2.7); MTHFD1 (hcv11462908) OR = 0.2 (0-0.9); MTHFD2 (rs702465) OR = 0.6 (0.4-0.9); MTHFD2 (rs7571842) OR = 0.6 (0.4-0.9); MTHFR (rs1801133) OR = 2.0 (1.2-3.1); MTRR (rs162036) OR = 3.0 (1.5-5.9); MTRR (rs10380) OR = 3.4 (1.6-7.1); MTRR (rs1801394) OR = 0.7 (0.5-0.9); MTRR (rs9332) OR = 2.7 (1.3-5.3); TYMS (rs2847149) OR = 2.2 (1.4-3.5); TYMS (rs1001761) OR = 2.4 (1.5-3.8); and TYMS (rs502396) OR = 2.1 (1.3-3.3)."}, {"disease": "Obesity", "pubmedid": "25612568", "sentence": "We compared the genotype distribution of five genetic Single Nucleotide Polymorphisms (SNPs) known to be associated with obesity and obesity co-morbidities (IGF2BP2 rs4402960, LPL rs320, LPL rs328, KCJN rs5219, and MTHFR rs1801133) between athletes (all male, n\u2009=\u2009461; endurance athletes n\u2009=\u2009254, sprint/power athletes n\u2009=\u2009207), and controls (all male, n\u2009=\u2009544) in Polish and Russian samples."}, {"disease": "Spina Bifida", "pubmedid": "19493349", "sentence": "With respect to spina bifida, we observed ORs with 95% confidence intervals that did not include 1.0 for the following SNPs (heterozygous or homozygous) relative to the reference genotype: BHMT (rs3733890) OR = 1.8 (1.1-3.1), CBS (rs2851391) OR = 2.0 (1.2-3.1); CBS (rs234713) OR = 2.9 (1.3-6.7); MTHFD1 (rs2236224) OR = 1.7 (1.1-2.7); MTHFD1 (hcv11462908) OR = 0.2 (0-0.9); MTHFD2 (rs702465) OR = 0.6 (0.4-0.9); MTHFD2 (rs7571842) OR = 0.6 (0.4-0.9); MTHFR (rs1801133) OR = 2.0 (1.2-3.1); MTRR (rs162036) OR = 3.0 (1.5-5.9); MTRR (rs10380) OR = 3.4 (1.6-7.1); MTRR (rs1801394) OR = 0.7 (0.5-0.9); MTRR (rs9332) OR = 2.7 (1.3-5.3); TYMS (rs2847149) OR = 2.2 (1.4-3.5); TYMS (rs1001761) OR = 2.4 (1.5-3.8); and TYMS (rs502396) OR = 2.1 (1.3-3.3)."}, {"disease": "Alzheimer's Disease", "pubmedid": "25359311", "sentence": "In this case-control study, we aimed to investigate whether single nucleotide polymorphisms in MTHFR (rs1801133), PICALM (3851719), CLU (rs11136000), and CR1 (rs6701713) are associated with AD."}, {"disease": "Impaired cognition", "pubmedid": "23353103", "sentence": "The investigation of the catechol-O-methyltransferase (COMT-[rs4680]) and methylenetetrahydrofolate reductase (MTHFR-[rs1801133]) polymorphisms' interaction might shed light into the pathogenetic mechanisms of the cognitive dysfunction in schizophrenia."}, {"disease": "Hypertensive disease", "pubmedid": "23591986", "sentence": "We also observed a significant association of 4 SNPs and the GRS with hypertension (ATP2B1 rs17249754: P = 0.02; CSK rs1378942: P = 0.02; CYP17A1 rs1004467: P = 0.02; MTHFR rs1801133: P = 0.03; GRS: P = 0.0004)."}, {"disease": "Hypertensive disease", "pubmedid": "23759979", "sentence": "The present study confirmed the significant association of ATP2B1 rs17249754 with risk of hypertension among Chinese children, but failed to replicate the association of CSK rs1378942, MTHFR rs1801133, CYP17A1 rs1004467, STK39 rs3754777 and FGF5 rs16998073 with BP/risk of hypertension."}, {"disease": "Hypertensive disease", "pubmedid": "23591986", "sentence": "We also observed a significant association of 4 SNPs and the GRS with hypertension (ATP2B1 rs17249754: P = 0.02; CSK rs1378942: P = 0.02; CYP17A1 rs1004467: P = 0.02; MTHFR rs1801133: P = 0.03; GRS: P = 0.0004)."}, {"disease": "Coronary Artery Disease", "pubmedid": "24315498", "sentence": "XRCC1 (rs1799782 and rs25487), XRCC3 (rs861539), MTHFR (rs1801133 and rs4846049), and NQO1 (rs1800566), to identify and characterize their potential gene-to-gene interactions in susceptibility to coronary artery disease (CAD) in Han Chinese."}, {"disease": "Migraine Disorders", "pubmedid": "22290307", "sentence": "By multivariate logistic stepwise regression analysis, type of migraine, regular and sufficient dietary intake, and methylenetetrahydrofolate reductase (MTHFR) C677T (rs1801133) and dopamine D2 receptor (DRD2) C939T (rs6275) polymorphisms were selected as significant factors that contribute independently to the development from migraine to MOH (P &lt; 0.05)."}, {"disease": "Macular degeneration", "pubmedid": "22065928", "sentence": "In contrast, there were significant differences in the genotype distribution between the controls and nAMD patients only for rs2301995 (ELN, p=0.022) and rs1801133 (MTHFR, p=2.50\u00d710(-3))."}, {"disease": "Age related macular degeneration", "pubmedid": "22065928", "sentence": "In contrast, there were significant differences in the genotype distribution between the controls and nAMD patients only for rs2301995 (ELN, p=0.022) and rs1801133 (MTHFR, p=2.50\u00d710(-3))."}, {"disease": "Colorectal Carcinoma", "pubmedid": "21422408", "sentence": "Factor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C&gt;T (rs1801133), fibrinogen gamma 10034C&gt;T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study."}, {"disease": "Colorectal Cancer", "pubmedid": "21422408", "sentence": "Factor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C&gt;T (rs1801133), fibrinogen gamma 10034C&gt;T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study."}, {"disease": "Factor V Leiden mutation", "pubmedid": "22707612", "sentence": "SNP in the following genes demonstrated association with thrombosis risk overall in the discovery or replication cohorts and were assessed using metaanalytic methods: factor V Leiden (FVL) rs6025 (OR 1.85, p = 0.02) and methylenetetrahydrofolate reductase (MTHFR) rs1801133 (OR 0.75, p = 0.04) in whites, and fibrinogen gamma (FGG) rs2066865 (OR 1.91, p = 0.01) in Hispanic Americans."}, {"disease": "Liver carcinoma", "pubmedid": "25318605", "sentence": "Results showed that six SNPs (MTHFR rs1801133, MTRR rs2287780, MTRR rs10380, FTHFD rs1127717, GART rs8971, and SHMT rs1979277) were significantly associated with HCC risk in Chinese population, with P values range from 2.26\u2009\u00d7\u200910(-4) to 0.035)."}, {"disease": "Hyperhomocysteinemia", "pubmedid": "23107763", "sentence": "All subjects were genotyped for 13 polymorphic variants in the genes of xenobiotics detoxification CYP1A1 (rs2606345, rs4646903, and rs1048943), GSTM1 (Ins/del), GSTT1 (Ins/del), ABCB1 rs1045642); immune and inflammation response IL-6 (rs1800795), TNF-a (rs1800629), MBL2 (rs7096206), CCR5 (rs333), NOS3 (rs1799983), angiotensin-converting enzyme ACE (rs4340), and occlusive vascular disease/hyperhomocysteinemia MTHFR (rs1801133)."}, {"disease": "Homocysteinemia", "pubmedid": "23107763", "sentence": "All subjects were genotyped for 13 polymorphic variants in the genes of xenobiotics detoxification CYP1A1 (rs2606345, rs4646903, and rs1048943), GSTM1 (Ins/del), GSTT1 (Ins/del), ABCB1 rs1045642); immune and inflammation response IL-6 (rs1800795), TNF-a (rs1800629), MBL2 (rs7096206), CCR5 (rs333), NOS3 (rs1799983), angiotensin-converting enzyme ACE (rs4340), and occlusive vascular disease/hyperhomocysteinemia MTHFR (rs1801133)."}, {"disease": "Aortic Aneurysm", "pubmedid": "24613192", "sentence": "For SNPs that had previously been associated with AAA presence, meta-analysis of currently available data together with the two study cohorts disclosed positive associations for the MMP-3 rs3025058 (OR, 1.15; 95% CI, 1.06-1.25; P = .0009) and MTHFR rs1801133 (OR, 1.07; 95% CI, 1.02-1.12; P = .0088)."}, {"disease": "Ovarian Carcinoma", "pubmedid": "22183302", "sentence": "Using PCR-RFLP and HRM analyses, we studied the distribution of BHMT (rs3733890), MTHFD1 (rs2236225), MTHFR (rs1801133), MTR (rs1805087), MTRR (rs1801394) and TCN2 (rs1801198) genotypes and alleles in patients with ovarian cancer (n\u00a0=\u00a0136) and controls (n\u00a0=\u00a0160)."}, {"disease": "Spina Bifida", "pubmedid": "19493349", "sentence": "With respect to spina bifida, we observed ORs with 95% confidence intervals that did not include 1.0 for the following SNPs (heterozygous or homozygous) relative to the reference genotype: BHMT (rs3733890) OR = 1.8 (1.1-3.1), CBS (rs2851391) OR = 2.0 (1.2-3.1); CBS (rs234713) OR = 2.9 (1.3-6.7); MTHFD1 (rs2236224) OR = 1.7 (1.1-2.7); MTHFD1 (hcv11462908) OR = 0.2 (0-0.9); MTHFD2 (rs702465) OR = 0.6 (0.4-0.9); MTHFD2 (rs7571842) OR = 0.6 (0.4-0.9); MTHFR (rs1801133) OR = 2.0 (1.2-3.1); MTRR (rs162036) OR = 3.0 (1.5-5.9); MTRR (rs10380) OR = 3.4 (1.6-7.1); MTRR (rs1801394) OR = 0.7 (0.5-0.9); MTRR (rs9332) OR = 2.7 (1.3-5.3); TYMS (rs2847149) OR = 2.2 (1.4-3.5); TYMS (rs1001761) OR = 2.4 (1.5-3.8); and TYMS (rs502396) OR = 2.1 (1.3-3.3)."}, {"disease": "Malignant neoplasm of ovary", "pubmedid": "22183302", "sentence": "Using PCR-RFLP and HRM analyses, we studied the distribution of BHMT (rs3733890), MTHFD1 (rs2236225), MTHFR (rs1801133), MTR (rs1805087), MTRR (rs1801394) and TCN2 (rs1801198) genotypes and alleles in patients with ovarian cancer (n\u00a0=\u00a0136) and controls (n\u00a0=\u00a0160)."}, {"disease": "Alzheimer's Disease", "pubmedid": "22015309", "sentence": "In this case-control study, we examined C677T and A1298C (rs1801133 and rs1801131) polymorphism in the methylenetetrahydrofolate reductase (MTHFR) genes and their correlation with plasma levels of homocysteine (Hcy) in AD and VaD cases and evaluated the gene-gene interaction (epistasis) with IL-6-174 G/C (rs1800795)."}, {"disease": "Aortic Aneurysm", "pubmedid": "24613192", "sentence": "For SNPs that had previously been associated with AAA presence, meta-analysis of currently available data together with the two study cohorts disclosed positive associations for the MMP-3 rs3025058 (OR, 1.15; 95% CI, 1.06-1.25; P = .0009) and MTHFR rs1801133 (OR, 1.07; 95% CI, 1.02-1.12; P = .0088)."}, {"disease": "Mental disorders", "pubmedid": "21819229", "sentence": "Two polymorphisms of the MTHFR gene, C677T (rs1801133) and A1298C (rs1801131), were analyzed in a sample of 100 Diagnostic and Statistical Manual of Mental Disorders-IV-diagnosed ADHD and 300 healthy controls using a polymerase chain reaction-restriction fragment length polymorphism method."}, {"disease": "Bipolar Disorder", "pubmedid": "24577139", "sentence": "We were unable to confirm an association between bipolar disorder and C677T polymorphism (rs1801133) of the MTHFR gene, as suggested in some previous studies."}, {"disease": "Malignant neoplasm of urinary bladder", "pubmedid": "23649653", "sentence": "Association between MTHFR Ala222Val (rs1801133) polymorphism and bladder cancer susceptibility: a systematic review and meta-analysis."}, {"disease": "Blood Coagulation Disorders", "pubmedid": "9409277", "sentence": "Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala223Val MTHFR) in patients with inherited thrombophilic coagulation defects."}, {"disease": "Malignant neoplasm of breast", "pubmedid": "23217001", "sentence": "Association of MTHFR Ala222Val (rs1801133) polymorphism and breast cancer susceptibility: An update meta-analysis based on 51 research studies."}, {"disease": "Malignant neoplasm of breast", "pubmedid": "24945727", "sentence": "Association of 677 C&gt;T (rs1801133) and 1298 A&gt;C (rs1801131) polymorphisms in the MTHFR gene and breast cancer susceptibility: a meta-analysis based on 57 individual studies."}, {"disease": "Cardiovascular Diseases", "pubmedid": "22103680", "sentence": "Genetic variation in folate-mediated one-carbon metabolism, other than the well-known effects of the MTHFR c.665C&gt;T (known as c.677 C&gt;T, rs1801133, p.Ala222Val), is predictive of cardiovascular disease biomarkers."}, {"disease": "Celiac Disease", "pubmedid": "21688148", "sentence": "Recently, a possible excess in the frequency of the MTHFR c.677C&gt;T (rs1801133) gene variant in CD patients was reported."}, {"disease": "Malignant tumor of cervix", "pubmedid": "21349258", "sentence": "Employing PCR-RFLPs and HRM analyses, we examined the prevalence of BHMT Arg239Gln (rs3733890), MTR Asp919Gly (rs1805087), MTHFR Ala222Val (rs1801133), MTHFD1 Arg653Gln (rs2236225) and MTRR Ile22Met (rs1801394) genotypes and alleles in patients with advanced cervical cancer (n=124) and controls (n=168)."}, {"disease": "Cluster Headache", "pubmedid": "20946434", "sentence": "An association between the 677C&gt;T polymorphism (rs1801133) in the methylenetetrahydrofolate reductase gene (MTHFR) and cluster headache is plausible, but has not been investigated."}, {"disease": "Colorectal Carcinoma", "pubmedid": "21422408", "sentence": "Factor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C&gt;T (rs1801133), fibrinogen gamma 10034C&gt;T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study."}, {"disease": "Colorectal Carcinoma", "pubmedid": "23437053", "sentence": "The 677C&gt;T (rs1801133) polymorphism in the MTHFR gene contributes to colorectal cancer risk: a meta-analysis based on 71 research studies."}, {"disease": "Coronary Arteriosclerosis", "pubmedid": "22440940", "sentence": "The rs1801133 polymorphism of the MTHFR gene affects risk of coronary artery disease."}, {"disease": "Coronary heart disease", "pubmedid": "22440940", "sentence": "The rs1801133 polymorphism of the MTHFR gene affects risk of coronary artery disease."}, {"disease": "Diabetes Mellitus, Non-Insulin-Dependent", "pubmedid": "21960995", "sentence": "The variant MTHFR-rs1801133 was the top signal for association with type 2 diabetes (OR = 0.78 (95%\u2009\u2009CI = 0.67-0.92), P = 0.003) and was also associated with 2\u2009h postload plasma glucose (P = 0.04), high-density lipoprotein cholesterol (P = 0.004), and total cholesterol (P = 0.01) in control subjects."}, {"disease": "Drug habituation", "pubmedid": "20421849", "sentence": "According to this practical and scientific demand, we aimed to investigate the relationship between seven top-ranked variants in the SZgene database [120-bpTR in DRD4, rs1801028 and rs6277 in DRD2, rs1019385 (T200G) in GRIN2B, rs1800532 in TPH1, rs1801133 (C677T) in MTHFR, rs2619528 (P1765) in DTNBP1] and prepulse inhibition (PPI) and habituation after acoustic stimulus (HAB)."}, {"disease": "Heart Diseases", "pubmedid": "24616178", "sentence": "The polymorphism 677C&gt;T (NM_005957.4:c.665C&gt;T/p.Ala222Val, rs1801133:C&gt;T) in methylenetetrahydrofolate reductase (MTHFR) results in mild enzymatic deficiency and increased risk for several complex traits including adverse reproductive outcomes, birth defects, and heart disease."}, {"disease": "Hypertensive disease", "pubmedid": "23591986", "sentence": "We also observed a significant association of 4 SNPs and the GRS with hypertension (ATP2B1 rs17249754: P = 0.02; CSK rs1378942: P = 0.02; CYP17A1 rs1004467: P = 0.02; MTHFR rs1801133: P = 0.03; GRS: P = 0.0004)."}, {"disease": "Malignant neoplasm of stomach", "pubmedid": "25337902", "sentence": "After shrinkage and adjusting for potential confounding factors, we found positive associations between MTHFR rs1801133 and stomach cancer (any T versus C/C, SB odds-ratio [SBOR]: 1.79, 95% posterior limits: 1.18, 2.71) and liver cancer (SBOR: 1.51, 95% posterior limits: 0.98, 2.32)."}, {"disease": "Myocardial Infarction", "pubmedid": "22440940", "sentence": "The rs1801133 polymorphism of methylenetetrahydrofolate reductase gene- the association with 5-year survival in patients with ST-elevation myocardial infarction."}, {"disease": "Nephroblastoma", "pubmedid": "25536437", "sentence": "The aim of this study was to investigate the association between MTHFR rs1801133 (C677T) and RFC-1 rs1051266 (G80A) genotypes with the risk of developing nephroblastoma and neuroblastoma."}, {"disease": "Neuroblastoma", "pubmedid": "25536437", "sentence": "The aim of this study was to investigate the association between MTHFR rs1801133 (C677T) and RFC-1 rs1051266 (G80A) genotypes with the risk of developing nephroblastoma and neuroblastoma."}, {"disease": "Osteoporosis", "pubmedid": "17712717", "sentence": "The C677T (rs1801133) polymorphism of MTHFR (methylenetetrahydrofolate reductase) has been associated with the risk of cardiovascular events, and also with osteoporosis in some studies."}, {"disease": "Ovarian Carcinoma", "pubmedid": "22183302", "sentence": "Using PCR-RFLP and HRM analyses, we studied the distribution of BHMT (rs3733890), MTHFD1 (rs2236225), MTHFR (rs1801133), MTR (rs1805087), MTRR (rs1801394) and TCN2 (rs1801198) genotypes and alleles in patients with ovarian cancer (n\u00a0=\u00a0136) and controls (n\u00a0=\u00a0160)."}, {"disease": "Parkinson Disease", "pubmedid": "25909872", "sentence": "Association of the rs1801133 variant in the MTHFR gene and sporadic Parkinson's disease."}, {"disease": "Schizophrenia", "pubmedid": "21980405", "sentence": "To gain insight into the neural and molecular mechanisms of error processing, we used functional MRI to examine effects of a genetic variant in methylenetetrahydrofolate reductase (MTHFR 677C&gt;T, rs1801133) that increases risk for schizophrenia and that has been specifically associated with increased perseverative errors among patients."}, {"disease": "Unipolar Depression", "pubmedid": "24532086", "sentence": "Low folate intake in the presence of the functional MTHFR 677 C &gt; T (rs1801133) polymorphism is an important cause of elevated homocysteine levels previously implicated in major depressive disorder (MDD) and many other chronic diseases."}, {"disease": "Diffuse Large B-Cell Lymphoma", "pubmedid": "23829278", "sentence": "The present study evaluated the impact of single gene polymorphisms (SNPs: rs1801133 and rs1801131 in the MTHFR gene; rs4149056 and rs11045879 in the SLC01B1 gene; and rs2032582 and rs1045642 in the ABCB1 transporter gene) on MTX blood levels and toxicity in samples from 69 patients with diffuse large-B-cell lymphoma (DLBCL) treated with high dose intravenous (HD IV) MTX, &gt; 2 g/m(2)."}, {"disease": "Migraine Disorders", "pubmedid": "21702266", "sentence": "Lastly, there may be a relationship between the MTHFR variant (SNP rs1801133) and migraine in this population."}, {"disease": "Migraine Disorders", "pubmedid": "22290307", "sentence": "By multivariate logistic stepwise regression analysis, type of migraine, regular and sufficient dietary intake, and methylenetetrahydrofolate reductase (MTHFR) C677T (rs1801133) and dopamine D2 receptor (DRD2) C939T (rs6275) polymorphisms were selected as significant factors that contribute independently to the development from migraine to MOH (P &lt; 0.05)."}, {"disease": "Liver and Intrahepatic Biliary Tract Carcinoma", "pubmedid": "25337902", "sentence": "After shrinkage and adjusting for potential confounding factors, we found positive associations between MTHFR rs1801133 and stomach cancer (any T versus C/C, SB odds-ratio [SBOR]: 1.79, 95% posterior limits: 1.18, 2.71) and liver cancer (SBOR: 1.51, 95% posterior limits: 0.98, 2.32)."}, {"disease": "Cervix carcinoma", "pubmedid": "21349258", "sentence": "Employing PCR-RFLPs and HRM analyses, we examined the prevalence of BHMT Arg239Gln (rs3733890), MTR Asp919Gly (rs1805087), MTHFR Ala222Val (rs1801133), MTHFD1 Arg653Gln (rs2236225) and MTRR Ile22Met (rs1801394) genotypes and alleles in patients with advanced cervical cancer (n=124) and controls (n=168)."}, {"disease": "Impaired cognition", "pubmedid": "23353103", "sentence": "The investigation of the catechol-O-methyltransferase (COMT-[rs4680]) and methylenetetrahydrofolate reductase (MTHFR-[rs1801133]) polymorphisms' interaction might shed light into the pathogenetic mechanisms of the cognitive dysfunction in schizophrenia."}, {"disease": "Malignant neoplasm of liver", "pubmedid": "25337902", "sentence": "After shrinkage and adjusting for potential confounding factors, we found positive associations between MTHFR rs1801133 and stomach cancer (any T versus C/C, SB odds-ratio [SBOR]: 1.79, 95% posterior limits: 1.18, 2.71) and liver cancer (SBOR: 1.51, 95% posterior limits: 0.98, 2.32)."}, {"disease": "Factor V Leiden mutation", "pubmedid": "22707612", "sentence": "SNP in these genes showed association with venous thrombosis risk in whites: MTHFR rs1801131 (OR 1.51, p = 0.01), MTHFR rs1801133 (OR 0.70, p = 0.04), FVL rs6025 (OR 2.69, p = 0.002), and FGG rs2066865 (OR 1.49, p = 0.02) in whites."}, {"disease": "Hyperhomocysteinemia", "pubmedid": "23107763", "sentence": "All subjects were genotyped for 13 polymorphic variants in the genes of xenobiotics detoxification CYP1A1 (rs2606345, rs4646903, and rs1048943), GSTM1 (Ins/del), GSTT1 (Ins/del), ABCB1 rs1045642); immune and inflammation response IL-6 (rs1800795), TNF-a (rs1800629), MBL2 (rs7096206), CCR5 (rs333), NOS3 (rs1799983), angiotensin-converting enzyme ACE (rs4340), and occlusive vascular disease/hyperhomocysteinemia MTHFR (rs1801133)."}, {"disease": "Breast Carcinoma", "pubmedid": "23217001", "sentence": "Association of MTHFR Ala222Val (rs1801133) polymorphism and breast cancer susceptibility: An update meta-analysis based on 51 research studies."}, {"disease": "Breast Carcinoma", "pubmedid": "24945727", "sentence": "Association of 677 C&gt;T (rs1801133) and 1298 A&gt;C (rs1801131) polymorphisms in the MTHFR gene and breast cancer susceptibility: a meta-analysis based on 57 individual studies."}, {"disease": "Stomach Carcinoma", "pubmedid": "25337902", "sentence": "After shrinkage and adjusting for potential confounding factors, we found positive associations between MTHFR rs1801133 and stomach cancer (any T versus C/C, SB odds-ratio [SBOR]: 1.79, 95% posterior limits: 1.18, 2.71) and liver cancer (SBOR: 1.51, 95% posterior limits: 0.98, 2.32)."}, {"disease": "Carcinoma of bladder", "pubmedid": "23649653", "sentence": "Association between MTHFR Ala222Val (rs1801133) polymorphism and bladder cancer susceptibility: a systematic review and meta-analysis."}, {"disease": "Central neuroblastoma", "pubmedid": "25536437", "sentence": "The aim of this study was to investigate the association between MTHFR rs1801133 (C677T) and RFC-1 rs1051266 (G80A) genotypes with the risk of developing nephroblastoma and neuroblastoma."}, {"disease": "vascular disease occlusive", "pubmedid": "23107763", "sentence": "All subjects were genotyped for 13 polymorphic variants in the genes of xenobiotics detoxification CYP1A1 (rs2606345, rs4646903, and rs1048943), GSTM1 (Ins/del), GSTT1 (Ins/del), ABCB1 rs1045642); immune and inflammation response IL-6 (rs1800795), TNF-a (rs1800629), MBL2 (rs7096206), CCR5 (rs333), NOS3 (rs1799983), angiotensin-converting enzyme ACE (rs4340), and occlusive vascular disease/hyperhomocysteinemia MTHFR (rs1801133)."}, {"disease": "Cleft Lip with or without Cleft Palate", "pubmedid": "25808365", "sentence": "rs1801133C&gt;T polymorphism in MTHFR is a risk factor for nonsyndromic cleft lip with or without cleft palate in the Brazilian population."}, {"disease": "Ischemic stroke", "pubmedid": "25144711", "sentence": "In addition, MTHFR rs1801133 also was associated with cerebral hemorrhage (OR = 1.48; 95%CI, 1.16 to 1.89; P = 0.001) but not with ischemic stroke (OR = 1.08; 95%CI, 0.96 to 1.22; P = 0.210)."}, {"disease": "Malignant neoplasm of ovary", "pubmedid": "22183302", "sentence": "Using PCR-RFLP and HRM analyses, we studied the distribution of BHMT (rs3733890), MTHFD1 (rs2236225), MTHFR (rs1801133), MTR (rs1805087), MTRR (rs1801394) and TCN2 (rs1801198) genotypes and alleles in patients with ovarian cancer (n\u00a0=\u00a0136) and controls (n\u00a0=\u00a0160)."}, {"disease": "Attention deficit hyperactivity disorder", "pubmedid": "25079255", "sentence": "We hypothesized that ADHD related cognitive deficit could be attributed to abnormalities in the folate cycle and explored functional single nucleotide polymorphisms in methylenetetrahydrofolate dehydrogenase (rs2236225), reduced folate carrier (rs1051266), and methylenetetrahydrofolate reductase (rs1801131 and rs1801133) in families with ADHD probands (N = 185) and ethnically matched controls (N = 216) recruited following the DSM-IV."}, {"disease": "Major Depressive Disorder", "pubmedid": "24532086", "sentence": "Low folate intake in the presence of the functional MTHFR 677 C &gt; T (rs1801133) polymorphism is an important cause of elevated homocysteine levels previously implicated in major depressive disorder (MDD) and many other chronic diseases."}, {"disease": "Colorectal Cancer", "pubmedid": "21422408", "sentence": "Factor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C&gt;T (rs1801133), fibrinogen gamma 10034C&gt;T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study."}, {"disease": "Colorectal Cancer", "pubmedid": "23437053", "sentence": "The 677C&gt;T (rs1801133) polymorphism in the MTHFR gene contributes to colorectal cancer risk: a meta-analysis based on 71 research studies."}, {"disease": "Coronary Artery Disease", "pubmedid": "22440940", "sentence": "The rs1801133 polymorphism of the MTHFR gene affects risk of coronary artery disease."}, {"disease": "Ischemic Cerebrovascular Accident", "pubmedid": "25144711", "sentence": "In addition, MTHFR rs1801133 also was associated with cerebral hemorrhage (OR = 1.48; 95%CI, 1.16 to 1.89; P = 0.001) but not with ischemic stroke (OR = 1.08; 95%CI, 0.96 to 1.22; P = 0.210)."}, {"disease": "Homocysteinemia", "pubmedid": "23107763", "sentence": "All subjects were genotyped for 13 polymorphic variants in the genes of xenobiotics detoxification CYP1A1 (rs2606345, rs4646903, and rs1048943), GSTM1 (Ins/del), GSTT1 (Ins/del), ABCB1 rs1045642); immune and inflammation response IL-6 (rs1800795), TNF-a (rs1800629), MBL2 (rs7096206), CCR5 (rs333), NOS3 (rs1799983), angiotensin-converting enzyme ACE (rs4340), and occlusive vascular disease/hyperhomocysteinemia MTHFR (rs1801133)."}, {"disease": "Malignant tumor of cervix", "pubmedid": "21349258", "sentence": "Employing PCR-RFLPs and HRM analyses, we examined the prevalence of BHMT Arg239Gln (rs3733890), MTR Asp919Gly (rs1805087), MTHFR Ala222Val (rs1801133), MTHFD1 Arg653Gln (rs2236225) and MTRR Ile22Met (rs1801394) genotypes and alleles in patients with advanced cervical cancer (n=124) and controls (n=168)."}, {"disease": "Cervix carcinoma", "pubmedid": "21349258", "sentence": "Employing PCR-RFLPs and HRM analyses, we examined the prevalence of BHMT Arg239Gln (rs3733890), MTR Asp919Gly (rs1805087), MTHFR Ala222Val (rs1801133), MTHFD1 Arg653Gln (rs2236225) and MTRR Ile22Met (rs1801394) genotypes and alleles in patients with advanced cervical cancer (n=124) and controls (n=168)."}, {"disease": "Spina Bifida", "pubmedid": "19493349", "sentence": "With respect to spina bifida, we observed ORs with 95% confidence intervals that did not include 1.0 for the following SNPs (heterozygous or homozygous) relative to the reference genotype: BHMT (rs3733890) OR = 1.8 (1.1-3.1), CBS (rs2851391) OR = 2.0 (1.2-3.1); CBS (rs234713) OR = 2.9 (1.3-6.7); MTHFD1 (rs2236224) OR = 1.7 (1.1-2.7); MTHFD1 (hcv11462908) OR = 0.2 (0-0.9); MTHFD2 (rs702465) OR = 0.6 (0.4-0.9); MTHFD2 (rs7571842) OR = 0.6 (0.4-0.9); MTHFR (rs1801133) OR = 2.0 (1.2-3.1); MTRR (rs162036) OR = 3.0 (1.5-5.9); MTRR (rs10380) OR = 3.4 (1.6-7.1); MTRR (rs1801394) OR = 0.7 (0.5-0.9); MTRR (rs9332) OR = 2.7 (1.3-5.3); TYMS (rs2847149) OR = 2.2 (1.4-3.5); TYMS (rs1001761) OR = 2.4 (1.5-3.8); and TYMS (rs502396) OR = 2.1 (1.3-3.3)."}, {"disease": "Endometriosis", "pubmedid": "21429654", "sentence": "However, the exhaustive multifactor dimensionality reduction analysis revealed an epistatic interaction between rs1801133 of MTHFR and rs4244593 of PEMT in endometriosis-associated infertility (p=0.0240)."}, {"disease": "Hypertensive disease", "pubmedid": "23591986", "sentence": "We also observed a significant association of 4 SNPs and the GRS with hypertension (ATP2B1 rs17249754: P = 0.02; CSK rs1378942: P = 0.02; CYP17A1 rs1004467: P = 0.02; MTHFR rs1801133: P = 0.03; GRS: P = 0.0004)."}, {"disease": "Hypertensive disease", "pubmedid": "23759979", "sentence": "The present study confirmed the significant association of ATP2B1 rs17249754 with risk of hypertension among Chinese children, but failed to replicate the association of CSK rs1378942, MTHFR rs1801133, CYP17A1 rs1004467, STK39 rs3754777 and FGF5 rs16998073 with BP/risk of hypertension."}, {"disease": "Colorectal Carcinoma", "pubmedid": "21422408", "sentence": "Factor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C&gt;T (rs1801133), fibrinogen gamma 10034C&gt;T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study."}, {"disease": "5,10-Methylenetetrahydrofolate reductase deficiency", "pubmedid": "24521996", "sentence": "With the aim to conclusively validate the strongest associations so far reported, we selected the polymorphisms rs2227667 (SERPINE1), rs17501108 (HGF), rs3136685 (CCR7), rs16944 (IL1B), rs12147254 (TRAF3), rs1805087 (MTR), rs1800629 (TNF-\u03b1), rs7516435 (CASP9), rs1042265 (BAX), rs2234922 (mEH), and rs1801133 (MTHFR)."}, {"disease": "Colorectal Cancer", "pubmedid": "21422408", "sentence": "Factor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C&gt;T (rs1801133), fibrinogen gamma 10034C&gt;T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study."}, {"disease": "Diffuse Large B-Cell Lymphoma", "pubmedid": "23829278", "sentence": "The present study evaluated the impact of single gene polymorphisms (SNPs: rs1801133 and rs1801131 in the MTHFR gene; rs4149056 and rs11045879 in the SLC01B1 gene; and rs2032582 and rs1045642 in the ABCB1 transporter gene) on MTX blood levels and toxicity in samples from 69 patients with diffuse large-B-cell lymphoma (DLBCL) treated with high dose intravenous (HD IV) MTX, &gt; 2 g/m(2)."}, {"disease": "Intestinal Perforation", "pubmedid": "24980946", "sentence": "The combination of the selectin E (SELE) rs3917412 G&gt;A G/G and the methylentetrahydrofolate reductase (MTHFR) rs1801133 T/T genotypes was associated with a significantly increased risk for recurrence in both the training [RR = 4.103; 95% confidence interval (CI), 1.803-9.334; P = 0.001] and the validation cohorts (RR = 3.567; 95% CI, 1.253-10.151; P = 0.017) in the multiple regression analysis considering the stage, lymphovascular invasion, and bowel perforation as covariates."}, {"disease": "Recurrent tumor", "pubmedid": "24980946", "sentence": "Our findings suggest that the SELE rs3917412 and MTHFR rs1801133 SNPs could serve as pharmacogenetic predictors of tumor recurrence in patients with early-stage colon cancer treated with oxaliplatin-based adjuvant chemotherapy, thus allowing personalized selection of treatment to optimize clinical outcomes."}, {"disease": "Liver carcinoma", "pubmedid": "25318605", "sentence": "Results showed that six SNPs (MTHFR rs1801133, MTRR rs2287780, MTRR rs10380, FTHFD rs1127717, GART rs8971, and SHMT rs1979277) were significantly associated with HCC risk in Chinese population, with P values range from 2.26\u2009\u00d7\u200910(-4) to 0.035)."}, {"disease": "Malignant neoplasm of lung", "pubmedid": "22144047", "sentence": "A review was conducted of 136 patients treated with radiation therapy for lung cancer between 2001 and 2007, and who had prior genotyping of functional single-nucleotide polymorphisms in oxidative stress genes including superoxide dismutase 2 (SOD2; rs4880) and methylene tetrahydrofolate reductase (MTHFR; rs1801131, rs1801133)."}, {"disease": "Carcinoma of lung", "pubmedid": "22144047", "sentence": "A review was conducted of 136 patients treated with radiation therapy for lung cancer between 2001 and 2007, and who had prior genotyping of functional single-nucleotide polymorphisms in oxidative stress genes including superoxide dismutase 2 (SOD2; rs4880) and methylene tetrahydrofolate reductase (MTHFR; rs1801131, rs1801133)."}, {"disease": "5,10-Methylenetetrahydrofolate reductase deficiency", "pubmedid": "24521996", "sentence": "With the aim to conclusively validate the strongest associations so far reported, we selected the polymorphisms rs2227667 (SERPINE1), rs17501108 (HGF), rs3136685 (CCR7), rs16944 (IL1B), rs12147254 (TRAF3), rs1805087 (MTR), rs1800629 (TNF-\u03b1), rs7516435 (CASP9), rs1042265 (BAX), rs2234922 (mEH), and rs1801133 (MTHFR)."}, {"disease": "Spina Bifida", "pubmedid": "19493349", "sentence": "With respect to spina bifida, we observed ORs with 95% confidence intervals that did not include 1.0 for the following SNPs (heterozygous or homozygous) relative to the reference genotype: BHMT (rs3733890) OR = 1.8 (1.1-3.1), CBS (rs2851391) OR = 2.0 (1.2-3.1); CBS (rs234713) OR = 2.9 (1.3-6.7); MTHFD1 (rs2236224) OR = 1.7 (1.1-2.7); MTHFD1 (hcv11462908) OR = 0.2 (0-0.9); MTHFD2 (rs702465) OR = 0.6 (0.4-0.9); MTHFD2 (rs7571842) OR = 0.6 (0.4-0.9); MTHFR (rs1801133) OR = 2.0 (1.2-3.1); MTRR (rs162036) OR = 3.0 (1.5-5.9); MTRR (rs10380) OR = 3.4 (1.6-7.1); MTRR (rs1801394) OR = 0.7 (0.5-0.9); MTRR (rs9332) OR = 2.7 (1.3-5.3); TYMS (rs2847149) OR = 2.2 (1.4-3.5); TYMS (rs1001761) OR = 2.4 (1.5-3.8); and TYMS (rs502396) OR = 2.1 (1.3-3.3)."}, {"disease": "Coronary Artery Disease", "pubmedid": "24315498", "sentence": "XRCC1 (rs1799782 and rs25487), XRCC3 (rs861539), MTHFR (rs1801133 and rs4846049), and NQO1 (rs1800566), to identify and characterize their potential gene-to-gene interactions in susceptibility to coronary artery disease (CAD) in Han Chinese."}, {"disease": "5,10-Methylenetetrahydrofolate reductase deficiency", "pubmedid": "24521996", "sentence": "With the aim to conclusively validate the strongest associations so far reported, we selected the polymorphisms rs2227667 (SERPINE1), rs17501108 (HGF), rs3136685 (CCR7), rs16944 (IL1B), rs12147254 (TRAF3), rs1805087 (MTR), rs1800629 (TNF-\u03b1), rs7516435 (CASP9), rs1042265 (BAX), rs2234922 (mEH), and rs1801133 (MTHFR)."}, {"disease": "Psoriasis", "pubmedid": "24118377", "sentence": "Methylentetrahydrofolatereductase (rs1801133) polymorphism and psoriasis: contribution to oxidative stress, lipid peroxidation and correlation with vascular adhesion protein 1, preliminary report."}], "core_attributes": {"allele_string": "G/A", "position": "11796321", "synonyms": ["RCV000003697", "VAR_009528", "2009_August_001_176_MTHFR_607093_0003", "rs386545618", "rs59514310", "RCV000153516", "RCV000144921", "rs4134713"], "chromosome": "1"}, "genename": "MTHFR", "genotype_frequency": "[{\"HGU-COLOMBO-SL:POP 2\": {\"A/A\": {\"count\": \"0\", \"frequency\": \"0\"}}}, {\"HGU-COLOMBO-SL:POP 3\": {\"A/A\": {\"count\": \"0\", \"frequency\": \"0\"}}}, {\"ENSEMBL:ENSEMBL_Watson\": {\"G/G\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_Venter\": {\"G/G\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:PGP\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"BUSHMAN:BUSHMAN_POP\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}]", "1000-genomes": {"GWD": {"11": 0, "0": 207, "00": 94, "01": 19, "1": 19}, "ACB": {"11": 3, "0": 162, "00": 69, "01": 24, "1": 30}, "BEB": {"11": 0, "0": 154, "00": 68, "01": 18, "1": 18}, "PEL": {"11": 14, "0": 109, "00": 38, "01": 33, "1": 61}, "LWK": {"11": 0, "0": 182, "00": 83, "01": 16, "1": 16}, "MSL": {"11": 0, "0": 157, "00": 72, "01": 13, "1": 13}, "GBR": {"11": 7, "0": 124, "00": 41, "01": 42, "1": 56}, "IBS": {"11": 17, "0": 120, "00": 30, "01": 60, "1": 94}, "ASW": {"11": 5, "0": 103, "00": 47, "01": 9, "1": 19}, "TSI": {"11": 26, "0": 114, "00": 33, "01": 48, "1": 100}, "KHV": {"11": 4, "0": 161, "00": 66, "01": 29, "1": 37}, "CEU": {"11": 9, "0": 141, "00": 51, "01": 39, "1": 57}, "SAS": {"11": 5, "0": 864, "00": 380, "01": 104, "1": 114}, "EAS": {"11": 54, "0": 708, "00": 258, "01": 192, "1": 300}, "AMR": {"11": 72, "0": 379, "00": 104, "01": 171, "1": 315}, "YRI": {"11": 1, "0": 192, "00": 85, "01": 22, "1": 24}, "CHB": {"11": 23, "0": 110, "00": 30, "01": 50, "1": 96}, "STU": {"11": 0, "0": 188, "00": 86, "01": 16, "1": 16}, "CHS": {"11": 8, "0": 153, "00": 56, "01": 41, "1": 57}, "ESN": {"11": 0, "0": 182, "00": 83, "01": 16, "1": 16}, "FIN": {"11": 6, "0": 143, "00": 50, "01": 43, "1": 55}, "AFR": {"11": 9, "0": 1185, "00": 533, "01": 119, "1": 137}, "GIH": {"11": 2, "0": 175, "00": 74, "01": 27, "1": 31}, "PJL": {"11": 1, "0": 167, "00": 72, "01": 23, "1": 25}, "EUR": {"11": 65, "0": 642, "00": 205, "01": 232, "1": 362}, "MXL": {"11": 12, "0": 71, "00": 19, "01": 33, "1": 57}, "PUR": {"11": 18, "0": 113, "00": 27, "01": 59, "1": 95}, "ITU": {"11": 2, "0": 180, "00": 80, "01": 20, "1": 24}, "CDX": {"11": 4, "0": 154, "00": 65, "01": 24, "1": 32}, "JPT": {"11": 15, "0": 130, "00": 41, "01": 48, "1": 78}, "CLM": {"11": 28, "0": 86, "00": 20, "01": 46, "1": 102}}, "version": "0.1", "effects": [{"genotype": "T/A", "odd_ratio": "", "title": "Novel associations of CPS1, MUT, NOX4, and DPEP1 with plasma homocysteine in a healthy population: a genome-wide evaluation of 13 974 participants in the Women's Genome Health Study.", "risk_allele": "A", "journal": "Circ Cardiovasc Genet", "initial": "13,974 European ancestry females", "mapped_trait": "homocysteine measurement", "effect": "Homocysteine levels", "evidences": "Initial: 13,974 European ancestry females, replication: 840 European ancestry females", "replication": "840 European ancestry females", "author": "Pare G", "date": "2009-04-01", "risk_allele_frequency": "", "pmid": "20031578", "risk": "Increased risk of Homocysteine levels", "population": ["Global"]}, {"genotype": "T/A", "odd_ratio": "", "title": "Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease.", "risk_allele": "A", "journal": "Am J Clin Nutr", "initial": "44,147 European ancestry individuals", "mapped_trait": "homocysteine measurement", "effect": "Homocysteine levels", "evidences": "Initial: 44,147 European ancestry individuals, replication: NA", "replication": "NA", "author": "van Meurs JB", "date": "2013-07-03", "risk_allele_frequency": "", "pmid": "23824729", "risk": "Increased risk of Homocysteine levels", "population": ["Global"]}], "associated_diseases": ["Spina Bifida", "Obesity", "Spina Bifida", "Alzheimer's Disease", "Impaired cognition", "Hypertensive disease", "Hypertensive disease", "Hypertensive disease", "Coronary Artery Disease", "Migraine Disorders", "Macular degeneration", "Age related macular degeneration", "Colorectal Carcinoma", "Colorectal Cancer", "Factor V Leiden mutation", "Liver carcinoma", "Hyperhomocysteinemia", "Homocysteinemia", "Aortic Aneurysm", "Ovarian Carcinoma", "Spina Bifida", "Malignant neoplasm of ovary", "Alzheimer's Disease", "Aortic Aneurysm", "Mental disorders", "Bipolar Disorder", "Malignant neoplasm of urinary bladder", "Blood Coagulation Disorders", "Malignant neoplasm of breast", "Malignant neoplasm of breast", "Cardiovascular Diseases", "Celiac Disease", "Malignant tumor of cervix", "Cluster Headache", "Colorectal Carcinoma", "Colorectal Carcinoma", "Coronary Arteriosclerosis", "Coronary heart disease", "Diabetes Mellitus, Non-Insulin-Dependent", "Drug habituation", "Heart Diseases", "Hypertensive disease", "Malignant neoplasm of stomach", "Myocardial Infarction", "Nephroblastoma", "Neuroblastoma", "Osteoporosis", "Ovarian Carcinoma", "Parkinson Disease", "Schizophrenia", "Unipolar Depression", "Diffuse Large B-Cell Lymphoma", "Migraine Disorders", "Migraine Disorders", "Liver and Intrahepatic Biliary Tract Carcinoma", "Cervix carcinoma", "Impaired cognition", "Malignant neoplasm of liver", "Factor V Leiden mutation", "Hyperhomocysteinemia", "Breast Carcinoma", "Breast Carcinoma", "Stomach Carcinoma", "Carcinoma of bladder", "Central neuroblastoma", "vascular disease occlusive", "Cleft Lip with or without Cleft Palate", "Ischemic stroke", "Malignant neoplasm of ovary", "Attention deficit hyperactivity disorder", "Major Depressive Disorder", "Colorectal Cancer", "Colorectal Cancer", "Coronary Artery Disease", "Ischemic Cerebrovascular Accident", "Homocysteinemia", "Malignant tumor of cervix", "Cervix carcinoma", "Spina Bifida", "Endometriosis", "Hypertensive disease", "Hypertensive disease", "Colorectal Carcinoma", "5,10-Methylenetetrahydrofolate reductase deficiency", "Colorectal Cancer", "Diffuse Large B-Cell Lymphoma", "Intestinal Perforation", "Recurrent tumor", "Liver carcinoma", "Malignant neoplasm of lung", "Carcinoma of lung", "5,10-Methylenetetrahydrofolate reductase deficiency", "Spina Bifida", "Coronary Artery Disease", "5,10-Methylenetetrahydrofolate reductase deficiency", "Psoriasis"]}
{"rsnumber": "rs13551", "core_attributes": {"allele_string": "T/C", "position": "23854472", "synonyms": ["2009_August_001_081_FUCA1_230000_0011", "VAR_002444", "RCV000000726", "rs2228423", "rs52796281", "rs3181585", "rs1126515", "rs17357792", "rs11549094", "17257"], "chromosome": "1"}, "genename": "FUCA1", "genotype_frequency": "[{\"ENSEMBL:ENSEMBL_Watson\": {\"T/T\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ILLUMINA-UK:YRI\": {\"T/C\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_Venter\": {\"T/C\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:YRI\": {\"T/C\": {\"count\": \"1\", \"frequency\": \"1\"}}}]", "1000-genomes": {"GWD": {"11": 1, "0": 210, "00": 98, "01": 14, "1": 16}, "ACB": {"11": 3, "0": 163, "00": 70, "01": 23, "1": 29}, "BEB": {"11": 0, "0": 150, "00": 64, "01": 22, "1": 22}, "PEL": {"11": 4, "0": 137, "00": 56, "01": 25, "1": 33}, "LWK": {"11": 2, "0": 175, "00": 78, "01": 19, "1": 23}, "MSL": {"11": 1, "0": 154, "00": 70, "01": 14, "1": 16}, "GBR": {"11": 10, "0": 118, "00": 38, "01": 42, "1": 62}, "IBS": {"11": 11, "0": 142, "00": 46, "01": 50, "1": 72}, "ASW": {"11": 1, "0": 101, "00": 41, "01": 19, "1": 21}, "TSI": {"11": 11, "0": 152, "00": 56, "01": 40, "1": 62}, "KHV": {"11": 10, "0": 131, "00": 42, "01": 47, "1": 67}, "CEU": {"11": 10, "0": 139, "00": 50, "01": 39, "1": 59}, "SAS": {"11": 9, "0": 845, "00": 365, "01": 115, "1": 133}, "EAS": {"11": 38, "0": 730, "00": 264, "01": 202, "1": 278}, "AMR": {"11": 21, "0": 524, "00": 198, "01": 128, "1": 170}, "YRI": {"11": 0, "0": 189, "00": 81, "01": 27, "1": 27}, "CHB": {"11": 5, "0": 163, "00": 65, "01": 33, "1": 43}, "STU": {"11": 0, "0": 184, "00": 82, "01": 20, "1": 20}, "CHS": {"11": 7, "0": 150, "00": 52, "01": 46, "1": 60}, "ESN": {"11": 1, "0": 186, "00": 88, "01": 10, "1": 12}, "FIN": {"11": 12, "0": 120, "00": 33, "01": 54, "1": 78}, "AFR": {"11": 9, "0": 1178, "00": 526, "01": 126, "1": 144}, "GIH": {"11": 2, "0": 175, "00": 74, "01": 27, "1": 31}, "PJL": {"11": 4, "0": 167, "00": 75, "01": 17, "1": 25}, "EUR": {"11": 54, "0": 671, "00": 223, "01": 225, "1": 333}, "MXL": {"11": 4, "0": 99, "00": 39, "01": 21, "1": 29}, "PUR": {"11": 5, "0": 158, "00": 59, "01": 40, "1": 50}, "ITU": {"11": 3, "0": 169, "00": 70, "01": 29, "1": 35}, "CDX": {"11": 9, "0": 128, "00": 44, "01": 40, "1": 58}, "JPT": {"11": 7, "0": 158, "00": 61, "01": 36, "1": 50}, "CLM": {"11": 8, "0": 130, "00": 44, "01": 42, "1": 58}}, "version": "0.1"}
{"rsnumber": "rs16946", "core_attributes": {"allele_string": "G/A", "position": "94464789", "synonyms": ["rs17401952", "rs11558247", "rs60417548"], "chromosome": "1"}, "genename": "ABCD3", "genotype_frequency": "[{\"ILLUMINA-UK:YRI\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_Watson\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:CEU\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:PGP\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"BUSHMAN:BUSHMAN_POP\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"BUSHMAN:BANTU\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}]", "1000-genomes": {"GWD": {"11": 2, "0": 203, "00": 92, "01": 19, "1": 23}, "ACB": {"11": 3, "0": 163, "00": 70, "01": 23, "1": 29}, "BEB": {"11": 8, "0": 118, "00": 40, "01": 38, "1": 54}, "PEL": {"11": 7, "0": 123, "00": 45, "01": 33, "1": 47}, "LWK": {"11": 1, "0": 164, "00": 66, "01": 32, "1": 34}, "MSL": {"11": 0, "0": 163, "00": 78, "01": 7, "1": 7}, "GBR": {"11": 31, "0": 79, "00": 20, "01": 39, "1": 101}, "IBS": {"11": 29, "0": 104, "00": 26, "01": 52, "1": 110}, "ASW": {"11": 1, "0": 102, "00": 42, "01": 18, "1": 20}, "TSI": {"11": 27, "0": 101, "00": 21, "01": 59, "1": 113}, "KHV": {"11": 1, "0": 167, "00": 69, "01": 29, "1": 31}, "CEU": {"11": 24, "0": 99, "00": 24, "01": 51, "1": 99}, "SAS": {"11": 42, "0": 691, "00": 244, "01": 203, "1": 287}, "EAS": {"11": 17, "0": 806, "00": 319, "01": 168, "1": 202}, "AMR": {"11": 56, "0": 431, "00": 140, "01": 151, "1": 263}, "YRI": {"11": 3, "0": 192, "00": 87, "01": 18, "1": 24}, "CHB": {"11": 7, "0": 150, "00": 54, "01": 42, "1": 56}, "STU": {"11": 5, "0": 149, "00": 52, "01": 45, "1": 55}, "CHS": {"11": 6, "0": 157, "00": 58, "01": 41, "1": 53}, "ESN": {"11": 0, "0": 187, "00": 88, "01": 11, "1": 11}, "FIN": {"11": 17, "0": 119, "00": 37, "01": 45, "1": 79}, "AFR": {"11": 10, "0": 1174, "00": 523, "01": 128, "1": 148}, "GIH": {"11": 9, "0": 148, "00": 54, "01": 40, "1": 58}, "PJL": {"11": 10, "0": 131, "00": 45, "01": 41, "1": 61}, "EUR": {"11": 128, "0": 502, "00": 128, "01": 246, "1": 502}, "MXL": {"11": 7, "0": 90, "00": 33, "01": 24, "1": 38}, "PUR": {"11": 25, "0": 114, "00": 35, "01": 44, "1": 94}, "ITU": {"11": 10, "0": 145, "00": 53, "01": 39, "1": 59}, "CDX": {"11": 2, "0": 160, "00": 69, "01": 22, "1": 26}, "JPT": {"11": 1, "0": 172, "00": 69, "01": 34, "1": 36}, "CLM": {"11": 17, "0": 104, "00": 27, "01": 50, "1": 84}}, "version": "0.1"}
{"rsnumber": "rs2230307", "core_attributes": {"allele_string": "G/A", "position": "99896369", "synonyms": ["rs52825060", "rs2274571", "rs57371286", "rs7536086", "rs386611124", "VAR_009230"], "chromosome": "1"}, "genename": "AGL", "genotype_frequency": "[{\"PERLEGEN:AFD_AFR_PANEL\": {\"G/G\": {\"count\": \"23\", \"frequency\": \"1\"}}}]", "1000-genomes": {"GWD": {"11": 0, "0": 220, "00": 107, "01": 6, "1": 6}, "ACB": {"11": 1, "0": 179, "00": 84, "01": 11, "1": 13}, "BEB": {"11": 0, "0": 163, "00": 77, "01": 9, "1": 9}, "PEL": {"11": 2, "0": 145, "00": 62, "01": 21, "1": 25}, "LWK": {"11": 0, "0": 197, "00": 98, "01": 1, "1": 1}, "MSL": {"11": 0, "0": 161, "00": 76, "01": 9, "1": 9}, "GBR": {"11": 1, "0": 170, "00": 81, "01": 8, "1": 10}, "IBS": {"11": 0, "0": 209, "00": 102, "01": 5, "1": 5}, "ASW": {"11": 0, "0": 120, "00": 59, "01": 2, "1": 2}, "TSI": {"11": 1, "0": 201, "00": 95, "01": 11, "1": 13}, "KHV": {"11": 4, "0": 174, "00": 79, "01": 16, "1": 24}, "CEU": {"11": 0, "0": 183, "00": 84, "01": 15, "1": 15}, "SAS": {"11": 3, "0": 923, "00": 437, "01": 49, "1": 55}, "EAS": {"11": 24, "0": 813, "00": 333, "01": 147, "1": 195}, "AMR": {"11": 6, "0": 603, "00": 262, "01": 79, "1": 91}, "YRI": {"11": 0, "0": 213, "00": 105, "01": 3, "1": 3}, "CHB": {"11": 7, "0": 159, "00": 63, "01": 33, "1": 47}, "STU": {"11": 1, "0": 190, "00": 89, "01": 12, "1": 14}, "CHS": {"11": 1, "0": 180, "00": 76, "01": 28, "1": 30}, "ESN": {"11": 0, "0": 191, "00": 92, "01": 7, "1": 7}, "FIN": {"11": 3, "0": 180, "00": 84, "01": 12, "1": 18}, "AFR": {"11": 1, "0": 1281, "00": 621, "01": 39, "1": 41}, "GIH": {"11": 0, "0": 193, "00": 90, "01": 13, "1": 13}, "PJL": {"11": 2, "0": 180, "00": 86, "01": 8, "1": 12}, "EUR": {"11": 5, "0": 943, "00": 446, "01": 51, "1": 61}, "MXL": {"11": 1, "0": 106, "00": 43, "01": 20, "1": 22}, "PUR": {"11": 1, "0": 188, "00": 85, "01": 18, "1": 20}, "ITU": {"11": 0, "0": 197, "00": 95, "01": 7, "1": 7}, "CDX": {"11": 4, "0": 146, "00": 57, "01": 32, "1": 40}, "JPT": {"11": 8, "0": 154, "00": 58, "01": 38, "1": 54}, "CLM": {"11": 2, "0": 164, "00": 72, "01": 20, "1": 24}}, "version": "0.1"}
{"rsnumber": "rs3753841", "disgenet-diseases": [{"disease": "Primary angle-closure glaucoma", "pubmedid": "23920366", "sentence": "Three susceptibility loci for primary angle-closure glaucoma (PACG) were recently identified: PLEKHA7 rs11024102, COL11A1 rs3753841, and rs1015213 located in the intergenic region between PCMTD1 and ST18."}, {"disease": "Primary angle-closure glaucoma", "pubmedid": "24474268", "sentence": "Recently, three genetic susceptibility loci for primary angle closure glaucoma (PACG) were identified: COL11A1 rs3753841, PCMTD1-ST18 rs1015213, and PLEKHA7 rs11024102."}, {"disease": "Primary angle-closure glaucoma", "pubmedid": "23847314", "sentence": "Three loci defined by single nucleotide polymorphisms (SNPs) rs11024102 in PLEKHA7, rs3753841 in COL11A1, and rs1015213 between the PCMTD1 and ST18 genes, recently have been associated with primary angle closure glaucoma (PACG)."}, {"disease": "Primary angle-closure glaucoma", "pubmedid": "23920366", "sentence": "Three susceptibility loci for primary angle-closure glaucoma (PACG) were recently identified: PLEKHA7 rs11024102, COL11A1 rs3753841, and rs1015213 located in the intergenic region between PCMTD1 and ST18."}, {"disease": "Primary angle-closure glaucoma", "pubmedid": "24474268", "sentence": "Recently, three genetic susceptibility loci for primary angle closure glaucoma (PACG) were identified: COL11A1 rs3753841, PCMTD1-ST18 rs1015213, and PLEKHA7 rs11024102."}, {"disease": "Primary angle-closure glaucoma", "pubmedid": "23847314", "sentence": "Three loci defined by single nucleotide polymorphisms (SNPs) rs11024102 in PLEKHA7, rs3753841 in COL11A1, and rs1015213 between the PCMTD1 and ST18 genes, recently have been associated with primary angle closure glaucoma (PACG)."}, {"disease": "Primary angle-closure glaucoma", "pubmedid": "23920366", "sentence": "Three susceptibility loci for primary angle-closure glaucoma (PACG) were recently identified: PLEKHA7 rs11024102, COL11A1 rs3753841, and rs1015213 located in the intergenic region between PCMTD1 and ST18."}, {"disease": "Primary angle-closure glaucoma", "pubmedid": "24474268", "sentence": "Recently, three genetic susceptibility loci for primary angle closure glaucoma (PACG) were identified: COL11A1 rs3753841, PCMTD1-ST18 rs1015213, and PLEKHA7 rs11024102."}, {"disease": "Primary angle-closure glaucoma", "pubmedid": "23920366", "sentence": "Three susceptibility loci for primary angle-closure glaucoma (PACG) were recently identified: PLEKHA7 rs11024102, COL11A1 rs3753841, and rs1015213 located in the intergenic region between PCMTD1 and ST18."}, {"disease": "Primary angle-closure glaucoma", "pubmedid": "24474268", "sentence": "Recently, three genetic susceptibility loci for primary angle closure glaucoma (PACG) were identified: COL11A1 rs3753841, PCMTD1-ST18 rs1015213, and PLEKHA7 rs11024102."}], "core_attributes": {"allele_string": "G/A", "position": "102914362", "synonyms": ["rs59687016", "rs17446207", "VAR_047726", "rs52824780"], "chromosome": "1"}, "genename": "COL11A1", "genotype_frequency": "[{\"ENSEMBL:ENSEMBL_Venter\": {\"G/G\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_Watson\": {\"A/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_celera\": {\"A/A\": {\"count\": \"2\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:CEU\": {\"G/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:PGP\": {\"A/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}]", "1000-genomes": {"GWD": {"11": 3, "0": 210, "00": 100, "01": 10, "1": 16}, "ACB": {"11": 15, "0": 147, "00": 66, "01": 15, "1": 45}, "BEB": {"11": 26, "0": 75, "00": 15, "01": 45, "1": 97}, "PEL": {"11": 60, "0": 33, "00": 8, "01": 17, "1": 137}, "LWK": {"11": 1, "0": 191, "00": 93, "01": 5, "1": 7}, "MSL": {"11": 0, "0": 170, "00": 85, "01": 0, "1": 0}, "GBR": {"11": 31, "0": 74, "00": 15, "01": 44, "1": 106}, "IBS": {"11": 48, "0": 70, "00": 11, "01": 48, "1": 144}, "ASW": {"11": 2, "0": 100, "00": 41, "01": 18, "1": 22}, "TSI": {"11": 39, "0": 86, "00": 18, "01": 50, "1": 128}, "KHV": {"11": 37, "0": 78, "00": 16, "01": 46, "1": 120}, "CEU": {"11": 32, "0": 80, "00": 13, "01": 54, "1": 118}, "SAS": {"11": 171, "0": 415, "00": 97, "01": 221, "1": 563}, "EAS": {"11": 246, "0": 311, "00": 53, "01": 205, "1": 697}, "AMR": {"11": 194, "0": 189, "00": 36, "01": 117, "1": 505}, "YRI": {"11": 0, "0": 209, "00": 101, "01": 7, "1": 7}, "CHB": {"11": 49, "0": 64, "00": 10, "01": 44, "1": 142}, "STU": {"11": 27, "0": 101, "00": 26, "01": 49, "1": 103}, "CHS": {"11": 54, "0": 59, "00": 8, "01": 43, "1": 151}, "ESN": {"11": 1, "0": 192, "00": 94, "01": 4, "1": 6}, "FIN": {"11": 38, "0": 77, "00": 16, "01": 45, "1": 121}, "AFR": {"11": 22, "0": 1219, "00": 580, "01": 59, "1": 103}, "GIH": {"11": 43, "0": 69, "00": 9, "01": 51, "1": 137}, "PJL": {"11": 42, "0": 74, "00": 20, "01": 34, "1": 118}, "EUR": {"11": 188, "0": 387, "00": 73, "01": 241, "1": 617}, "MXL": {"11": 37, "0": 32, "00": 5, "01": 22, "1": 96}, "PUR": {"11": 45, "0": 74, "00": 15, "01": 44, "1": 134}, "ITU": {"11": 33, "0": 96, "00": 27, "01": 42, "1": 108}, "CDX": {"11": 56, "0": 46, "00": 9, "01": 28, "1": 140}, "JPT": {"11": 50, "0": 64, "00": 10, "01": 44, "1": 144}, "CLM": {"11": 52, "0": 50, "00": 8, "01": 34, "1": 138}}, "version": "0.1", "effects": [{"genotype": "C/G", "odd_ratio": "", "title": "Genome-wide association analyses identify three new susceptibility loci for primary angle closure glaucoma.", "risk_allele": "G", "journal": "Nat Genet", "initial": "1,281 East Asian ancestry cases, 1,987 East Asian ancestry controls, 337 South Indian ancestry cases, 2,538 South Indian ancestry controls, 236 South East Asian ancestry cases, 5,083 South East Asian ancestry controls", "mapped_trait": "glaucoma", "effect": "Glaucoma (primary angle closure)", "evidences": "Initial: 1,281 East Asian ancestry cases, 1,987 East Asian ancestry controls, 337 South Indian ancestry cases, 2,538 South Indian ancestry controls, 236 South East Asian ancestry cases, 5,083 South East Asian ancestry controls, replication: 1,545 East Asian ancestry cases, 3,756 East Asian ancestry controls, 165 Saudi Arabian ancestry cases, 175 Saudi Arabian ancestry controls, 127 European ancestry cases, 4,703 European ancestry controls, 80 Indian ancestry cases, 309 Indian ancestry controls", "replication": "1,545 East Asian ancestry cases, 3,756 East Asian ancestry controls, 165 Saudi Arabian ancestry cases, 175 Saudi Arabian ancestry controls, 127 European ancestry cases, 4,703 European ancestry controls, 80 Indian ancestry cases, 309 Indian ancestry controls", "author": "Vithana EN", "date": "2012-08-26", "risk_allele_frequency": "", "pmid": "22922875", "risk": "Increased risk of Glaucoma (primary angle closure)", "population": ["Global"]}, {"genotype": "C/G", "odd_ratio": "", "title": "Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma.", "risk_allele": "G", "journal": "Nat Genet", "initial": "5,612 East Asian ancestry cases, 12,451 East Asian ancestry controls, 337 Indian ancestry cases, 2,538 Indian ancestry controls, 576 European ancestry cases, 4,940 European ancestry controls", "mapped_trait": "primary angle closure glaucoma", "effect": "Glaucoma (primary angle closure)", "evidences": "Initial: 5,612 East Asian ancestry cases, 12,451 East Asian ancestry controls, 337 Indian ancestry cases, 2,538 Indian ancestry controls, 576 European ancestry cases, 4,940 European ancestry controls, replication: 430 European ancestry cases, 3,133 European ancestry controls, 90 Nepalese ancestry cases, 205 Nepalese ancestry controls, 2,340 East Asian ancestry cases, 3,865 East Asian ancestry controls, 628 South Asian ancestry cases, 552 South Asian ancestry controls, 99 Latin American cases, 224 Latin American controls, 391 Saudi Arabian ancestry cases, 1,659 Saudi Arabian ancestry controls", "replication": "430 European ancestry cases, 3,133 European ancestry controls, 90 Nepalese ancestry cases, 205 Nepalese ancestry controls, 2,340 East Asian ancestry cases, 3,865 East Asian ancestry controls, 628 South Asian ancestry cases, 552 South Asian ancestry controls, 99 Latin American cases, 224 Latin American controls, 391 Saudi Arabian ancestry cases, 1,659 Saudi Arabian ancestry controls", "author": "Khor CC", "date": "2016-04-04", "risk_allele_frequency": "", "pmid": "27064256", "risk": "Increased risk of Glaucoma (primary angle closure)", "population": ["Global"]}, {"genotype": "C/G", "odd_ratio": "", "title": "Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma.", "risk_allele": "G", "journal": "Nat Genet", "initial": "5,612 East Asian ancestry cases, 12,451 East Asian ancestry controls, 337 Indian ancestry cases, 2,538 Indian ancestry controls, 576 European ancestry cases, 4,940 European ancestry controls", "mapped_trait": "primary angle closure glaucoma", "effect": "Glaucoma (primary angle closure)", "evidences": "Initial: 5,612 East Asian ancestry cases, 12,451 East Asian ancestry controls, 337 Indian ancestry cases, 2,538 Indian ancestry controls, 576 European ancestry cases, 4,940 European ancestry controls, replication: 430 European ancestry cases, 3,133 European ancestry controls, 90 Nepalese ancestry cases, 205 Nepalese ancestry controls, 2,340 East Asian ancestry cases, 3,865 East Asian ancestry controls, 628 South Asian ancestry cases, 552 South Asian ancestry controls, 99 Latin American cases, 224 Latin American controls, 391 Saudi Arabian ancestry cases, 1,659 Saudi Arabian ancestry controls", "replication": "430 European ancestry cases, 3,133 European ancestry controls, 90 Nepalese ancestry cases, 205 Nepalese ancestry controls, 2,340 East Asian ancestry cases, 3,865 East Asian ancestry controls, 628 South Asian ancestry cases, 552 South Asian ancestry controls, 99 Latin American cases, 224 Latin American controls, 391 Saudi Arabian ancestry cases, 1,659 Saudi Arabian ancestry controls", "author": "Khor CC", "date": "2016-04-04", "risk_allele_frequency": "", "pmid": "27064256", "risk": "Increased risk of Glaucoma (primary angle closure)", "population": ["Global"]}], "associated_diseases": ["Primary angle-closure glaucoma", "Primary angle-closure glaucoma", "Primary angle-closure glaucoma", "Primary angle-closure glaucoma", "Primary angle-closure glaucoma", "Primary angle-closure glaucoma", "Primary angle-closure glaucoma", "Primary angle-closure glaucoma", "Primary angle-closure glaucoma", "Primary angle-closure glaucoma"]}
{"rsnumber": "rs3138142", "core_attributes": {"allele_string": "C/T", "position": "55721801", "synonyms": null, "chromosome": "12"}, "genename": "RP11-644F5.10", "genotype_frequency": "[{\"CSHL-HAPMAP:HapMap-JPT\": {\"C/C\": {\"count\": \"43\", \"frequency\": \"1\"}}}]", "1000-genomes": {"GWD": {"11": 1, "0": 221, "00": 109, "01": 3, "1": 5}, "ACB": {"11": 0, "0": 183, "00": 87, "01": 9, "1": 9}, "BEB": {"11": 13, "0": 109, "00": 36, "01": 37, "1": 63}, "PEL": {"11": 0, "0": 158, "00": 73, "01": 12, "1": 12}, "LWK": {"11": 0, "0": 196, "00": 97, "01": 2, "1": 2}, "MSL": {"11": 0, "0": 170, "00": 85, "01": 0, "1": 0}, "GBR": {"11": 2, "0": 144, "00": 56, "01": 32, "1": 36}, "IBS": {"11": 4, "0": 172, "00": 69, "01": 34, "1": 42}, "ASW": {"11": 0, "0": 117, "00": 56, "01": 5, "1": 5}, "TSI": {"11": 3, "0": 172, "00": 68, "01": 36, "1": 42}, "KHV": {"11": 4, "0": 164, "00": 69, "01": 26, "1": 34}, "CEU": {"11": 4, "0": 159, "00": 64, "01": 31, "1": 39}, "SAS": {"11": 75, "0": 617, "00": 203, "01": 211, "1": 361}, "EAS": {"11": 8, "0": 889, "00": 393, "01": 103, "1": 119}, "AMR": {"11": 2, "0": 624, "00": 279, "01": 66, "1": 70}, "YRI": {"11": 0, "0": 216, "00": 108, "01": 0, "1": 0}, "CHB": {"11": 1, "0": 187, "00": 85, "01": 17, "1": 19}, "STU": {"11": 14, "0": 132, "00": 44, "01": 44, "1": 72}, "CHS": {"11": 3, "0": 184, "00": 82, "01": 20, "1": 26}, "ESN": {"11": 0, "0": 197, "00": 98, "01": 1, "1": 1}, "FIN": {"11": 4, "0": 165, "00": 70, "01": 25, "1": 33}, "AFR": {"11": 1, "0": 1300, "00": 640, "01": 20, "1": 22}, "GIH": {"11": 21, "0": 118, "00": 36, "01": 46, "1": 88}, "PJL": {"11": 11, "0": 132, "00": 47, "01": 38, "1": 60}, "EUR": {"11": 17, "0": 812, "00": 327, "01": 158, "1": 192}, "MXL": {"11": 0, "0": 121, "00": 57, "01": 7, "1": 7}, "PUR": {"11": 1, "0": 178, "00": 75, "01": 28, "1": 30}, "ITU": {"11": 16, "0": 126, "00": 40, "01": 46, "1": 78}, "CDX": {"11": 0, "0": 155, "00": 62, "01": 31, "1": 31}, "JPT": {"11": 0, "0": 199, "00": 95, "01": 9, "1": 9}, "CLM": {"11": 1, "0": 167, "00": 74, "01": 19, "1": 21}}, "version": "0.1", "effects": [{"genotype": "A/T", "odd_ratio": "", "title": "Meta-analysis of gene-environment-wide association scans accounting for education level identifies additional loci for refractive error.", "risk_allele": "T", "journal": "Nat Commun", "initial": "2,604 Erasmus Rucphen population isolate individuals, 456 Sardinian population isolate individuals, 36,976 European ancestry individuals, 5,971 East Asian ancestry individuals, 2,256 Malay ancestry individuals, 2,088 Indian ancestry individuals", "mapped_trait": "self reported educational attainment, refractive error measurement", "effect": "Spherical equivalent (joint main effects and education interaction)", "evidences": "Initial: 2,604 Erasmus Rucphen population isolate individuals, 456 Sardinian population isolate individuals, 36,976 European ancestry individuals, 5,971 East Asian ancestry individuals, 2,256 Malay ancestry individuals, 2,088 Indian ancestry individuals, replication: NA", "replication": "NA", "author": "Fan Q", "date": "2016-03-29", "risk_allele_frequency": "", "pmid": "27020472", "risk": "Increased risk of Spherical equivalent (joint main effects and education interaction)", "population": ["Global"]}, {"genotype": "A/T", "odd_ratio": "", "title": "Meta-analysis of gene-environment-wide association scans accounting for education level identifies additional loci for refractive error.", "risk_allele": "T", "journal": "Nat Commun", "initial": "2,604 Erasmus Rucphen population isolate individuals, 456 Sardinian population isolate individuals, 36,976 European ancestry individuals, 5,971 East Asian ancestry individuals, 2,256 Malay ancestry individuals, 2,088 Indian ancestry individuals", "mapped_trait": "self reported educational attainment, refractive error measurement", "effect": "Spherical equivalent (joint main effects and education interaction)", "evidences": "Initial: 2,604 Erasmus Rucphen population isolate individuals, 456 Sardinian population isolate individuals, 36,976 European ancestry individuals, 5,971 East Asian ancestry individuals, 2,256 Malay ancestry individuals, 2,088 Indian ancestry individuals, replication: NA", "replication": "NA", "author": "Fan Q", "date": "2016-03-29", "risk_allele_frequency": "", "pmid": "27020472", "risk": "Increased risk of Spherical equivalent (joint main effects and education interaction)", "population": ["Global"]}]}
{"rsnumber": "rs10380", "disgenet-diseases": [{"disease": "Spina Bifida", "pubmedid": "19493349", "sentence": "With respect to spina bifida, we observed ORs with 95% confidence intervals that did not include 1.0 for the following SNPs (heterozygous or homozygous) relative to the reference genotype: BHMT (rs3733890) OR = 1.8 (1.1-3.1), CBS (rs2851391) OR = 2.0 (1.2-3.1); CBS (rs234713) OR = 2.9 (1.3-6.7); MTHFD1 (rs2236224) OR = 1.7 (1.1-2.7); MTHFD1 (hcv11462908) OR = 0.2 (0-0.9); MTHFD2 (rs702465) OR = 0.6 (0.4-0.9); MTHFD2 (rs7571842) OR = 0.6 (0.4-0.9); MTHFR (rs1801133) OR = 2.0 (1.2-3.1); MTRR (rs162036) OR = 3.0 (1.5-5.9); MTRR (rs10380) OR = 3.4 (1.6-7.1); MTRR (rs1801394) OR = 0.7 (0.5-0.9); MTRR (rs9332) OR = 2.7 (1.3-5.3); TYMS (rs2847149) OR = 2.2 (1.4-3.5); TYMS (rs1001761) OR = 2.4 (1.5-3.8); and TYMS (rs502396) OR = 2.1 (1.3-3.3)."}, {"disease": "Spina Bifida", "pubmedid": "19493349", "sentence": "With respect to spina bifida, we observed ORs with 95% confidence intervals that did not include 1.0 for the following SNPs (heterozygous or homozygous) relative to the reference genotype: BHMT (rs3733890) OR = 1.8 (1.1-3.1), CBS (rs2851391) OR = 2.0 (1.2-3.1); CBS (rs234713) OR = 2.9 (1.3-6.7); MTHFD1 (rs2236224) OR = 1.7 (1.1-2.7); MTHFD1 (hcv11462908) OR = 0.2 (0-0.9); MTHFD2 (rs702465) OR = 0.6 (0.4-0.9); MTHFD2 (rs7571842) OR = 0.6 (0.4-0.9); MTHFR (rs1801133) OR = 2.0 (1.2-3.1); MTRR (rs162036) OR = 3.0 (1.5-5.9); MTRR (rs10380) OR = 3.4 (1.6-7.1); MTRR (rs1801394) OR = 0.7 (0.5-0.9); MTRR (rs9332) OR = 2.7 (1.3-5.3); TYMS (rs2847149) OR = 2.2 (1.4-3.5); TYMS (rs1001761) OR = 2.4 (1.5-3.8); and TYMS (rs502396) OR = 2.1 (1.3-3.3)."}, {"disease": "Liver carcinoma", "pubmedid": "25318605", "sentence": "Results showed that six SNPs (MTHFR rs1801133, MTRR rs2287780, MTRR rs10380, FTHFD rs1127717, GART rs8971, and SHMT rs1979277) were significantly associated with HCC risk in Chinese population, with P values range from 2.26\u2009\u00d7\u200910(-4) to 0.035)."}, {"disease": "Spina Bifida", "pubmedid": "19493349", "sentence": "With respect to spina bifida, we observed ORs with 95% confidence intervals that did not include 1.0 for the following SNPs (heterozygous or homozygous) relative to the reference genotype: BHMT (rs3733890) OR = 1.8 (1.1-3.1), CBS (rs2851391) OR = 2.0 (1.2-3.1); CBS (rs234713) OR = 2.9 (1.3-6.7); MTHFD1 (rs2236224) OR = 1.7 (1.1-2.7); MTHFD1 (hcv11462908) OR = 0.2 (0-0.9); MTHFD2 (rs702465) OR = 0.6 (0.4-0.9); MTHFD2 (rs7571842) OR = 0.6 (0.4-0.9); MTHFR (rs1801133) OR = 2.0 (1.2-3.1); MTRR (rs162036) OR = 3.0 (1.5-5.9); MTRR (rs10380) OR = 3.4 (1.6-7.1); MTRR (rs1801394) OR = 0.7 (0.5-0.9); MTRR (rs9332) OR = 2.7 (1.3-5.3); TYMS (rs2847149) OR = 2.2 (1.4-3.5); TYMS (rs1001761) OR = 2.4 (1.5-3.8); and TYMS (rs502396) OR = 2.1 (1.3-3.3)."}, {"disease": "Malignant neoplasm of breast", "pubmedid": "24130171", "sentence": "We found three single-nucleotide polymorphisms in those genes associated with LINE-1 methylation: SLC19A1 (rs1051266); MTRR (rs10380) and MTHFR (rs1537514), one of which was also associated with breast cancer risk: MTHFR (rs1537514)."}, {"disease": "Breast Carcinoma", "pubmedid": "24130171", "sentence": "We found three single-nucleotide polymorphisms in those genes associated with LINE-1 methylation: SLC19A1 (rs1051266); MTRR (rs10380) and MTHFR (rs1537514), one of which was also associated with breast cancer risk: MTHFR (rs1537514)."}, {"disease": "Malignant neoplasm of breast", "pubmedid": "24130171", "sentence": "We found three single-nucleotide polymorphisms in those genes associated with LINE-1 methylation: SLC19A1 (rs1051266); MTRR (rs10380) and MTHFR (rs1537514), one of which was also associated with breast cancer risk: MTHFR (rs1537514)."}, {"disease": "Spina Bifida", "pubmedid": "19493349", "sentence": "With respect to spina bifida, we observed ORs with 95% confidence intervals that did not include 1.0 for the following SNPs (heterozygous or homozygous) relative to the reference genotype: BHMT (rs3733890) OR = 1.8 (1.1-3.1), CBS (rs2851391) OR = 2.0 (1.2-3.1); CBS (rs234713) OR = 2.9 (1.3-6.7); MTHFD1 (rs2236224) OR = 1.7 (1.1-2.7); MTHFD1 (hcv11462908) OR = 0.2 (0-0.9); MTHFD2 (rs702465) OR = 0.6 (0.4-0.9); MTHFD2 (rs7571842) OR = 0.6 (0.4-0.9); MTHFR (rs1801133) OR = 2.0 (1.2-3.1); MTRR (rs162036) OR = 3.0 (1.5-5.9); MTRR (rs10380) OR = 3.4 (1.6-7.1); MTRR (rs1801394) OR = 0.7 (0.5-0.9); MTRR (rs9332) OR = 2.7 (1.3-5.3); TYMS (rs2847149) OR = 2.2 (1.4-3.5); TYMS (rs1001761) OR = 2.4 (1.5-3.8); and TYMS (rs502396) OR = 2.1 (1.3-3.3)."}, {"disease": "Pancreatic carcinoma", "pubmedid": "18515090", "sentence": "His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk."}, {"disease": "Malignant neoplasm of pancreas", "pubmedid": "18515090", "sentence": "His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk."}, {"disease": "Breast Carcinoma", "pubmedid": "24130171", "sentence": "We found three single-nucleotide polymorphisms in those genes associated with LINE-1 methylation: SLC19A1 (rs1051266); MTRR (rs10380) and MTHFR (rs1537514), one of which was also associated with breast cancer risk: MTHFR (rs1537514)."}, {"disease": "Liver carcinoma", "pubmedid": "25318605", "sentence": "Results showed that six SNPs (MTHFR rs1801133, MTRR rs2287780, MTRR rs10380, FTHFD rs1127717, GART rs8971, and SHMT rs1979277) were significantly associated with HCC risk in Chinese population, with P values range from 2.26\u2009\u00d7\u200910(-4) to 0.035)."}, {"disease": "Malignant neoplasm of breast", "pubmedid": "24130171", "sentence": "We found three single-nucleotide polymorphisms in those genes associated with LINE-1 methylation: SLC19A1 (rs1051266); MTRR (rs10380) and MTHFR (rs1537514), one of which was also associated with breast cancer risk: MTHFR (rs1537514)."}, {"disease": "Breast Carcinoma", "pubmedid": "24130171", "sentence": "We found three single-nucleotide polymorphisms in those genes associated with LINE-1 methylation: SLC19A1 (rs1051266); MTRR (rs10380) and MTHFR (rs1537514), one of which was also associated with breast cancer risk: MTHFR (rs1537514)."}, {"disease": "Spina Bifida", "pubmedid": "19493349", "sentence": "With respect to spina bifida, we observed ORs with 95% confidence intervals that did not include 1.0 for the following SNPs (heterozygous or homozygous) relative to the reference genotype: BHMT (rs3733890) OR = 1.8 (1.1-3.1), CBS (rs2851391) OR = 2.0 (1.2-3.1); CBS (rs234713) OR = 2.9 (1.3-6.7); MTHFD1 (rs2236224) OR = 1.7 (1.1-2.7); MTHFD1 (hcv11462908) OR = 0.2 (0-0.9); MTHFD2 (rs702465) OR = 0.6 (0.4-0.9); MTHFD2 (rs7571842) OR = 0.6 (0.4-0.9); MTHFR (rs1801133) OR = 2.0 (1.2-3.1); MTRR (rs162036) OR = 3.0 (1.5-5.9); MTRR (rs10380) OR = 3.4 (1.6-7.1); MTRR (rs1801394) OR = 0.7 (0.5-0.9); MTRR (rs9332) OR = 2.7 (1.3-5.3); TYMS (rs2847149) OR = 2.2 (1.4-3.5); TYMS (rs1001761) OR = 2.4 (1.5-3.8); and TYMS (rs502396) OR = 2.1 (1.3-3.3)."}], "core_attributes": {"allele_string": "C/T", "position": "7897078", "synonyms": ["rs9282886", "rs1134946", "rs52810705", "VAR_014944", "rs2287782", "RCV000144924", "rs60582795", "RCV000126880", "rs3197331", "rs17354145"], "chromosome": "5"}, "genename": "MTRR", "genotype_frequency": "[{\"SNP500CANCER:AFR1\": {\"T/T\": {\"count\": \"0\", \"frequency\": \"0\"}}}, {\"ENSEMBL:ENSEMBL_Watson\": {\"C/C\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ILLUMINA-UK:YRI\": {\"T/C\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:PGP\": {\"T/C\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"BUSHMAN:BANTU\": {\"T/C\": {\"count\": \"1\", \"frequency\": \"1\"}}}]", "1000-genomes": {"GWD": {"11": 20, "0": 131, "00": 38, "01": 55, "1": 95}, "ACB": {"11": 10, "0": 131, "00": 45, "01": 41, "1": 61}, "BEB": {"11": 3, "0": 146, "00": 63, "01": 20, "1": 26}, "PEL": {"11": 22, "0": 89, "00": 26, "01": 37, "1": 81}, "LWK": {"11": 8, "0": 132, "00": 41, "01": 50, "1": 66}, "MSL": {"11": 15, "0": 98, "00": 28, "01": 42, "1": 72}, "GBR": {"11": 0, "0": 167, "00": 77, "01": 13, "1": 13}, "IBS": {"11": 2, "0": 191, "00": 86, "01": 19, "1": 23}, "ASW": {"11": 4, "0": 87, "00": 30, "01": 27, "1": 35}, "TSI": {"11": 2, "0": 185, "00": 80, "01": 25, "1": 29}, "KHV": {"11": 5, "0": 163, "00": 69, "01": 25, "1": 35}, "CEU": {"11": 1, "0": 171, "00": 73, "01": 25, "1": 27}, "SAS": {"11": 15, "0": 832, "00": 358, "01": 116, "1": 146}, "EAS": {"11": 16, "0": 862, "00": 374, "01": 114, "1": 146}, "AMR": {"11": 38, "0": 479, "00": 170, "01": 139, "1": 215}, "YRI": {"11": 10, "0": 142, "00": 44, "01": 54, "1": 74}, "CHB": {"11": 2, "0": 176, "00": 75, "01": 26, "1": 30}, "STU": {"11": 3, "0": 177, "00": 78, "01": 21, "1": 27}, "CHS": {"11": 3, "0": 176, "00": 74, "01": 28, "1": 34}, "ESN": {"11": 12, "0": 116, "00": 29, "01": 58, "1": 82}, "FIN": {"11": 2, "0": 183, "00": 86, "01": 11, "1": 15}, "AFR": {"11": 79, "0": 837, "00": 255, "01": 327, "1": 485}, "GIH": {"11": 3, "0": 173, "00": 73, "01": 27, "1": 33}, "PJL": {"11": 4, "0": 156, "00": 64, "01": 28, "1": 36}, "EUR": {"11": 7, "0": 897, "00": 402, "01": 93, "1": 107}, "MXL": {"11": 8, "0": 88, "00": 32, "01": 24, "1": 40}, "PUR": {"11": 5, "0": 158, "00": 59, "01": 40, "1": 50}, "ITU": {"11": 2, "0": 180, "00": 80, "01": 20, "1": 24}, "CDX": {"11": 4, "0": 164, "00": 75, "01": 14, "1": 22}, "JPT": {"11": 2, "0": 183, "00": 81, "01": 21, "1": 25}, "CLM": {"11": 3, "0": 144, "00": 53, "01": 38, "1": 44}}, "version": "0.1", "associated_diseases": ["Spina Bifida", "Spina Bifida", "Liver carcinoma", "Spina Bifida", "Malignant neoplasm of breast", "Breast Carcinoma", "Malignant neoplasm of breast", "Spina Bifida", "Pancreatic carcinoma", "Malignant neoplasm of pancreas", "Breast Carcinoma", "Liver carcinoma", "Malignant neoplasm of breast", "Breast Carcinoma", "Spina Bifida"]}
{"rsnumber": "rs12026", "disgenet-diseases": [{"disease": "Diabetes", "pubmedid": "19151417", "sentence": "PON1 A(-162)G and PON2 Ala148Gly genotypes, cystatin C, HbA1c, high density lipoprotein cholesterol (HDLC), waist circumference (waist), and duration of diabetes were included in the regression analysis with log(e) (ln) of PON1 mass as the dependent variable."}, {"disease": "Diabetes Mellitus", "pubmedid": "19151417", "sentence": "PON1 A(-162)G and PON2 Ala148Gly genotypes, cystatin C, HbA1c, high density lipoprotein cholesterol (HDLC), waist circumference (waist), and duration of diabetes were included in the regression analysis with log(e) (ln) of PON1 mass as the dependent variable."}, {"disease": "Diabetes", "pubmedid": "19151417", "sentence": "PON1 A(-162)G and PON2 Ala148Gly genotypes, cystatin C, HbA1c, high density lipoprotein cholesterol (HDLC), waist circumference (waist), and duration of diabetes were included in the regression analysis with log(e) (ln) of PON1 mass as the dependent variable."}, {"disease": "Diabetes Mellitus", "pubmedid": "19151417", "sentence": "PON1 A(-162)G and PON2 Ala148Gly genotypes, cystatin C, HbA1c, high density lipoprotein cholesterol (HDLC), waist circumference (waist), and duration of diabetes were included in the regression analysis with log(e) (ln) of PON1 mass as the dependent variable."}, {"disease": "Diabetes", "pubmedid": "17096118", "sentence": "We examined the relationship between variation at the C311S and A148G polymorphisms (together with PON2 intronic variant rs12704795) and indices of renal dysfunction (progression to micro- and macroalbuminuria, plasma creatinine increases) in 3,374 newly diagnosed type 2 diabetic subjects from the UK Prospective Diabetes Study followed prospectively (median 14.0 years), using proportional hazards models, adjusted for sex, ethnicity and other known or putative risk factors."}, {"disease": "Diabetes", "pubmedid": "19151417", "sentence": "PON1 A(-162)G and PON2 Ala148Gly genotypes, cystatin C, HbA1c, high density lipoprotein cholesterol (HDLC), waist circumference (waist), and duration of diabetes were included in the regression analysis with log(e) (ln) of PON1 mass as the dependent variable."}, {"disease": "Diabetes Mellitus", "pubmedid": "17096118", "sentence": "We examined the relationship between variation at the C311S and A148G polymorphisms (together with PON2 intronic variant rs12704795) and indices of renal dysfunction (progression to micro- and macroalbuminuria, plasma creatinine increases) in 3,374 newly diagnosed type 2 diabetic subjects from the UK Prospective Diabetes Study followed prospectively (median 14.0 years), using proportional hazards models, adjusted for sex, ethnicity and other known or putative risk factors."}, {"disease": "Diabetes Mellitus", "pubmedid": "19151417", "sentence": "PON1 A(-162)G and PON2 Ala148Gly genotypes, cystatin C, HbA1c, high density lipoprotein cholesterol (HDLC), waist circumference (waist), and duration of diabetes were included in the regression analysis with log(e) (ln) of PON1 mass as the dependent variable."}, {"disease": "Coronary Artery Disease", "pubmedid": "14996478", "sentence": "We analyzed two common polymorphisms in PON1 (i.e., M/L55 and R/Q 192 mutations) and PON2 (i.e., G/A148 and C/S311 mutations) in 352 high-risk patients with angiographically defined CAD."}], "core_attributes": {"allele_string": "G/C", "position": "95411704", "synonyms": ["rs1058082", "rs3173814", "VAR_006045", "rs61490355", "rs17846386", "rs11545941", "RCV000007501", "rs17354640", "rs17859428", "11209", "2010_April_001_065_PON2_602447_0002", "rs17876142"], "chromosome": "7"}, "genename": "PON2", "genotype_frequency": "[{\"HUMANGENOME_JCVI:J. Craig Venter\": {\"G/C\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ILLUMINA-UK:YRI\": {\"C/C\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_Venter\": {\"G/C\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_Watson\": {\"G/C\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:YRI\": {\"C/C\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"BUSHMAN:BUSHMAN_POP\": {\"G/C\": {\"count\": \"1\", \"frequency\": \"1\"}}}]", "1000-genomes": {"GWD": {"11": 10, "0": 161, "00": 58, "01": 45, "1": 65}, "ACB": {"11": 9, "0": 137, "00": 50, "01": 37, "1": 55}, "BEB": {"11": 10, "0": 110, "00": 34, "01": 42, "1": 62}, "PEL": {"11": 7, "0": 126, "00": 48, "01": 30, "1": 44}, "LWK": {"11": 13, "0": 124, "00": 38, "01": 48, "1": 74}, "MSL": {"11": 4, "0": 121, "00": 40, "01": 41, "1": 49}, "GBR": {"11": 4, "0": 138, "00": 52, "01": 34, "1": 42}, "IBS": {"11": 4, "0": 172, "00": 69, "01": 34, "1": 42}, "ASW": {"11": 8, "0": 86, "00": 33, "01": 20, "1": 36}, "TSI": {"11": 2, "0": 169, "00": 64, "01": 41, "1": 45}, "KHV": {"11": 8, "0": 159, "00": 68, "01": 23, "1": 39}, "CEU": {"11": 4, "0": 153, "00": 58, "01": 37, "1": 45}, "SAS": {"11": 69, "0": 599, "00": 179, "01": 241, "1": 379}, "EAS": {"11": 21, "0": 809, "00": 326, "01": 157, "1": 199}, "AMR": {"11": 22, "0": 530, "00": 205, "01": 120, "1": 164}, "YRI": {"11": 14, "0": 142, "00": 48, "01": 46, "1": 74}, "CHB": {"11": 4, "0": 167, "00": 68, "01": 31, "1": 39}, "STU": {"11": 12, "0": 127, "00": 37, "01": 53, "1": 77}, "CHS": {"11": 3, "0": 168, "00": 66, "01": 36, "1": 42}, "ESN": {"11": 9, "0": 130, "00": 40, "01": 50, "1": 68}, "FIN": {"11": 14, "0": 122, "00": 37, "01": 48, "1": 76}, "AFR": {"11": 67, "0": 901, "00": 307, "01": 287, "1": 421}, "GIH": {"11": 15, "0": 125, "00": 37, "01": 51, "1": 81}, "PJL": {"11": 19, "0": 109, "00": 32, "01": 45, "1": 83}, "EUR": {"11": 28, "0": 754, "00": 280, "01": 194, "1": 250}, "MXL": {"11": 4, "0": 98, "00": 38, "01": 22, "1": 30}, "PUR": {"11": 5, "0": 161, "00": 62, "01": 37, "1": 47}, "ITU": {"11": 13, "0": 128, "00": 39, "01": 50, "1": 76}, "CDX": {"11": 1, "0": 150, "00": 58, "01": 34, "1": 36}, "JPT": {"11": 5, "0": 165, "00": 66, "01": 33, "1": 43}, "CLM": {"11": 6, "0": 145, "00": 57, "01": 31, "1": 43}}, "version": "0.1", "associated_diseases": ["Diabetes", "Diabetes Mellitus", "Diabetes", "Diabetes Mellitus", "Diabetes", "Diabetes", "Diabetes Mellitus", "Diabetes Mellitus", "Coronary Artery Disease"]}
{"rsnumber": "rs42524", "disgenet-diseases": [{"disease": "Intracranial Aneurysm", "pubmedid": "19035720", "sentence": "Polymorphism rs42524 of COL1A2 and sporadic intracranial aneurysms in the Chinese population."}, {"disease": "Intracranial Aneurysm", "pubmedid": "19426706", "sentence": "A coding polymorphism (rs42524) in COL1A2 has previously been associated with intracranial aneurysms."}, {"disease": "Intracranial Aneurysm", "pubmedid": "22815632", "sentence": "In this study, we investigated the association of rs42524 in the alpha-2 type I collagen (COL1A2) gene, which has been identified as a risk variant for intracranial aneurysm, with nAMD and PCV in a Han Chinese population."}], "core_attributes": {"allele_string": "C/A/G/T", "position": "94413927", "synonyms": ["rs59646360", "VAR_001867", "rs17857444", "rs10383941", "rs1136007"], "chromosome": "7"}, "genename": "COL1A2", "genotype_frequency": "[{\"HUMANGENOME_JCVI:J. Craig Venter\": {\"G/G\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ILLUMINA-UK:YRI\": {\"G/G\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_Venter\": {\"G/G\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_Watson\": {\"G/G\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:CEU\": {\"G/G\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:YRI\": {\"G/G\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:PGP\": {\"G/G\": {\"count\": \"1\", \"frequency\": \"1\"}}}]", "1000-genomes": {"GWD": {"11": 83, "0": 32, "00": 2, "01": 28, "1": 194}, "ACB": {"11": 75, "0": 22, "00": 1, "01": 20, "1": 170}, "BEB": {"11": 41, "0": 54, "00": 9, "01": 36, "1": 118}, "PEL": {"11": 75, "0": 11, "00": 1, "01": 9, "1": 159}, "LWK": {"11": 81, "0": 19, "00": 1, "01": 17, "1": 179}, "MSL": {"11": 68, "0": 17, "00": 0, "01": 17, "1": 153}, "GBR": {"11": 53, "0": 37, "00": 0, "01": 37, "1": 143}, "IBS": {"11": 54, "0": 56, "00": 3, "01": 50, "1": 158}, "ASW": {"11": 46, "0": 16, "00": 1, "01": 14, "1": 106}, "TSI": {"11": 60, "0": 54, "00": 7, "01": 40, "1": 160}, "KHV": {"11": 75, "0": 27, "00": 3, "01": 21, "1": 171}, "CEU": {"11": 57, "0": 50, "00": 8, "01": 34, "1": 148}, "SAS": {"11": 228, "0": 320, "00": 59, "01": 202, "1": 658}, "EAS": {"11": 415, "0": 96, "00": 7, "01": 82, "1": 912}, "AMR": {"11": 251, "0": 104, "00": 8, "01": 88, "1": 590}, "YRI": {"11": 93, "0": 15, "00": 0, "01": 15, "1": 201}, "CHB": {"11": 89, "0": 14, "00": 0, "01": 14, "1": 192}, "STU": {"11": 50, "0": 66, "00": 14, "01": 38, "1": 138}, "CHS": {"11": 90, "0": 16, "00": 1, "01": 14, "1": 194}, "ESN": {"11": 89, "0": 10, "00": 0, "01": 10, "1": 188}, "FIN": {"11": 61, "0": 45, "00": 7, "01": 31, "1": 153}, "AFR": {"11": 535, "0": 131, "00": 5, "01": 121, "1": 1191}, "GIH": {"11": 51, "0": 59, "00": 7, "01": 45, "1": 147}, "PJL": {"11": 45, "0": 63, "00": 12, "01": 39, "1": 129}, "EUR": {"11": 285, "0": 242, "00": 25, "01": 192, "1": 762}, "MXL": {"11": 46, "0": 20, "00": 2, "01": 16, "1": 108}, "PUR": {"11": 70, "0": 38, "00": 4, "01": 30, "1": 170}, "ITU": {"11": 41, "0": 78, "00": 17, "01": 44, "1": 126}, "CDX": {"11": 65, "0": 31, "00": 3, "01": 25, "1": 155}, "JPT": {"11": 96, "0": 8, "00": 0, "01": 8, "1": 200}, "CLM": {"11": 60, "0": 35, "00": 1, "01": 33, "1": 153}}, "version": "0.1", "associated_diseases": ["Intracranial Aneurysm", "Intracranial Aneurysm", "Intracranial Aneurysm"]}
{"rsnumber": "rs31668", "core_attributes": {"allele_string": "G/A", "position": "87423890", "synonyms": ["rs3815242", "rs1636904", "rs58096005", "rs10358522"], "chromosome": "7"}, "genename": "ABCB4", "genotype_frequency": "[{\"EGP_SNPS:EGP_YORUB-PANEL\": {\"A/A\": {\"count\": \"12\", \"frequency\": \"1\"}}}, {\"EGP_SNPS:EGP_AD-PANEL\": {\"A/A\": {\"count\": \"15\", \"frequency\": \"1\"}}}, {\"HUMANGENOME_JCVI:J. Craig Venter\": {\"A/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ILLUMINA-UK:YRI\": {\"A/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_Watson\": {\"A/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"ENSEMBL:ENSEMBL_Venter\": {\"A/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:CEU\": {\"A/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:YRI\": {\"A/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}, {\"COMPLETE_GENOMICS:PGP\": {\"A/A\": {\"count\": \"1\", \"frequency\": \"1\"}}}]", "1000-genomes": {"GWD": {"11": 94, "0": 20, "00": 1, "01": 18, "1": 206}, "ACB": {"11": 82, "0": 16, "00": 2, "01": 12, "1": 176}, "BEB": {"11": 61, "0": 25, "00": 0, "01": 25, "1": 147}, "PEL": {"11": 63, "0": 22, "00": 0, "01": 22, "1": 148}, "LWK": {"11": 89, "0": 11, "00": 1, "01": 9, "1": 187}, "MSL": {"11": 73, "0": 12, "00": 0, "01": 12, "1": 158}, "GBR": {"11": 82, "0": 8, "00": 0, "01": 8, "1": 172}, "IBS": {"11": 87, "0": 21, "00": 1, "01": 19, "1": 193}, "ASW": {"11": 50, "0": 11, "00": 0, "01": 11, "1": 111}, "TSI": {"11": 88, "0": 21, "00": 2, "01": 17, "1": 193}, "KHV": {"11": 52, "0": 54, "00": 7, "01": 40, "1": 144}, "CEU": {"11": 90, "0": 9, "00": 0, "01": 9, "1": 189}, "SAS": {"11": 379, "0": 118, "00": 8, "01": 102, "1": 860}, "EAS": {"11": 266, "0": 284, "00": 46, "01": 192, "1": 724}, "AMR": {"11": 282, "0": 66, "00": 1, "01": 64, "1": 628}, "YRI": {"11": 97, "0": 11, "00": 0, "01": 11, "1": 205}, "CHB": {"11": 50, "0": 60, "00": 7, "01": 46, "1": 146}, "STU": {"11": 79, "0": 26, "00": 3, "01": 20, "1": 178}, "CHS": {"11": 60, "0": 59, "00": 14, "01": 31, "1": 151}, "ESN": {"11": 90, "0": 9, "00": 0, "01": 9, "1": 189}, "FIN": {"11": 83, "0": 16, "00": 0, "01": 16, "1": 182}, "AFR": {"11": 575, "0": 90, "00": 4, "01": 82, "1": 1232}, "GIH": {"11": 81, "0": 23, "00": 1, "01": 21, "1": 183}, "PJL": {"11": 73, "0": 27, "00": 4, "01": 19, "1": 165}, "EUR": {"11": 430, "0": 75, "00": 3, "01": 69, "1": 929}, "MXL": {"11": 50, "0": 15, "00": 1, "01": 13, "1": 113}, "PUR": {"11": 91, "0": 13, "00": 0, "01": 13, "1": 195}, "ITU": {"11": 85, "0": 17, "00": 0, "01": 17, "1": 187}, "CDX": {"11": 52, "0": 50, "00": 9, "01": 32, "1": 136}, "JPT": {"11": 52, "0": 61, "00": 9, "01": 43, "1": 147}, "CLM": {"11": 78, "0": 16, "00": 0, "01": 16, "1": 172}}, "version": "0.1"}